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ABSTRACT 
The goal of this dissertation research is to understand proteolytic 
processing of the polymerase polyprotein in murine coronavirus mouse 
hepatitis virus (MHV). MHV polymerase is encoded by gene 1 as a 
polyprotein, which is proteolytically processed into mature proteins by three 
proposed proteinase domains. The first papain-like cysteine proteinase 
domain (PCP-1) has been shown to autocleave the N-terminal peptide, p28 
from the putative MHV polymerase polyprotein. This study was designed to 
further understand the p28 processing event, focusing on the catalytic sites of 
PCP-1 and the cleavage site recognized by PCP-1 to release p28. 
The predicted PCP-1 domain at the 5'-end 3.5-4.3 kb of gene 1 was 
confirmed by in-frame deletion analysis. In addition, the proteolytic activity 
of PCP-1 was shown to be partially inhibited by cysteine proteinase inhibitors 
but not by serine, aspartic, or metallo- proteinases inhibitors, supporting the 
proposal that this proteinase is a papain-like cysteine proteinase. By site-
specific mutagenesis, Cys-1137 and His-1288 were identified to be the 
catalytic sites of PCP-1. Thus, MHV PCP-1 is indeed a new member of the 
family ofpapain-like cysteine proteinases. 
To determine the p28 cleavage site recognized by MHV PCP-1, the 
radiolabeled in vitro cleaved product adjacent to p28 was subjected to N-
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terminal sequencing, and the result indicated that the cleavage occurred 
between Gly-24 7 and Val-248. By extensive site-specific mutagenesis of 
amino acid residues surrounding this cleavage site, Gly-247(Pl) and Arg-246 
(P2) were characterized as major determinants for cleavage site recognition 
by MHV PCP-1. In addition, some surrounding residues such as Arg-243 (P5) 
are probably required to maintain an important conformation of the cleavage 
site. 
This work is an important step towards the understanding of the 
complete proteolytic processing pathway of MHV polymerase polyprotein. 
Future studies can be directed toward characterizing additional putative 
cleavage sites for MHV PCP-1 and determining what effect blocking the 
cleavage of p28 will have on coronavirus RNA replication. 
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CHAPTER I 
IN'IRODUCTION 
eoronaviruses and their replication 
Coronaviruses are a family of large, enveloped positive-strand ( +) 
RNA viruses which are widespread in nature (Wege et al., 1982; Siddell et 
al., 1983). This family of viruses consists of 11 members, including avian 
infectious bronchitis virus (IBV), mouse hepatitis virus (MHV), bovine 
coronavirus (BCV), and human coronavirus (HCV). Coronaviruses are of 
clinical and economical importance because they cause a variety of 
diseases, mainly in respiratory, gastrointestinal and neurological systems, 
such as common cold in humans; enteritis in cows, pigs, turkeys, cats and 
mice; and encephalitis in mice and cats. Mouse hepatitis virus (MHV), a 
prototype coronavirus, has been extensively studied to understand the 
molecular biology of coronaviruses (Spaan et al., 1988; Lai, 1990). The 
neurotropic strain of mouse hepatitis virus (MHV-JHM) can induce 
demyelination after injection into the brains of mice and serves as a model 
system for studying demyelination diseases such as multiple sclerosis 
(Weiner, 1973; Knobler et al., 1982; Fleming et al., 1987). 
The coronavirion is a crown-like particle with a lipid-bilayer 
membrane outside and a helical encapsidated RNA genome inside (Siddell 
et al., 1983). These enveloped viruses are composed of three or four 
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atructural proteins: the petal-shaped spike protein (S) projecting from the 
surface of the envelope giving coronavirus its distinctive morphology, the 
membrane embedded matrix protein (M), the hemagglutinin esterase (HE, 
expressed only in some virus strains) and the nucleocapsid protein (N) 
which surrounds the virion RNA. The viral genomic RNA is a single-
strand positive-sense RNA molecule which is capped at the 5' end and 
polyadenylated at the 3' end (Yogo et al., 1977; Lai and Stahlman, 1978). In 
MHV, the viral RNA contains 8 genes and is about 31 kilobases in length, 
thus making it the largest viral RNA genome identified to date (Pachuk et 
al., 1989; Lee et al., 1991). The virion RNA itself carries all the genetic 
information for coronavirus replication and is infectious when it is 
transfected into eukaryotic cells (Wege et al., 1978). 
Coronavirus replication occurs exclusively in the cytoplasm of the 
infected cells (Brayton et al., 1981; Wilhelmsen et al., 1981). Upon viral 
infection, virions use the spike proteins to attach to the receptors on the 
surface of the target cell and penetrate the cell by immediate membrane 
fusion or endocytosis. When viral genomic RNA is released into the host 
cell cytoplasm, the first event is the translation of the viral specific RNA-
dependent RNA polymerase from the incoming genome. Using the genome 
as the template, this polymerase transcribes a genomic-length negative-
strand RNA, which in turn serves as the template for the transcription of 
genomic RNA and seven subgenomic viral messenger RNAs. These 
mRNAs have the same 3' end, extend in the 5' direction for various lengths 
and contain an identical leader sequence (approximately 72 nucleotides) at 
3 
the 51 end (Lai and Stohlman, 1978; 1981; Lai et al., 1981; 1982a; 1983; Spaan 
et al., 1983). For each of these nested-set mRNAs, only the 5' most gene is 
translated into viral proteins (Siddell et al., 1983). For instance, although 
the genomic mRNA contains a total of 8 genes, only gene 1 at its 5' end is 
translated which results in the synthesis of the polymerase (Leibowitz et 
al., 1982b; Denison and Perlman, 1986). Following protein synthesis and 
viral replication, virions are assembled in the rough endoplasmic 
reticulum of the cytoplasm and bud out of the cell. Thus, like many 
positive-strand RNA viruses, coronavirus RNA is infectious and the viral 
replication cycle takes place in the cytoplasm of the infected cell. 
Two unique features have been observed during coronavirus 
replication: (1) discontinuous transcription and (2) high frequency RNA 
recombination. The identical leader sequence (approximately 72 
nucleotides) at the 5' end of the seven subgenomic RNAs is derived from the 
5' end of the genomic RNA by a discontinuous transcription mechanism 
(Barie et al., 1983; Spaan et al., 1983; Lai et al., 1983; 1984; Makino et al., 
1986b; 1988; 1989; Baker and Lai, 1990). For this unique discontinuous 
transcription, several models have been proposed, among which "leader-
primed" transcription is the most favored and has been supported by a 
large body of evidence (Barie et al., 1983; Spaan et al., 1983; Lai et al., 1983; 
1984; Makino et al., 1986b; 1988; 1989; Baker and Lai, 1990). According to 
this model (Fig. 1), free leader RNAs (approximately 72 nucleotides) are 
synthesized from the negative RNA template during coronavirus 
replication. These leader RNAs disassociate from ~he template and 
4 
Fig. 1. Model of "leader-primed" transcription of coronavirus mRNAs. A. 
"Leader-primed" transcription in the coronavirus RNA replication cycle. 
The viral genomic RNA ( +) released in the infected cell is first used to 
synthesize the viral specific RNA-dependent RNA polymerase. This 
polymerase transcribes a genomic-length negative RNA (-) from the viral 
genomic RNA ( +) and uses it as the template for the replication of a nested-
set genomic and subgenomic mRNAs (+) shown below. A nested-set 
subgenomic negative RNAs (-)are also indicated as the potential templates 
for the transcription of the subgenomic mRNAs ( + ). The solid squares 
represent leader RNA. B. An example of the intergenic sequences. Partial 
sequences of a free leader RNA is denoted above the template of a genomic-
length negative RNA. The intergenic sequence preceding gene 6 is shown 
to be hybridized to the free leader RNA by homologous sequences. The 
arrow indicates the consensus sequence UCUAAC in the leader RNA. 
(The figure was modified from Lai, 1990). 
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rehybridize to the homologous sequence (several repeats of AGAUU) in the 
region between each gene. The leader RNA serves as a primer for the 
transcription of each of the seven subgenomic mRNAs. Transcription of 
these subgenomic mRNAs initiates at different intergenic sites and extends 
to the 3' end along the negative RNA template. This results in a nested-set 
structure of these genomic and subgenomic mRNAs. 
The second unique feature, high frequency RNA recombination, was 
observed during mixed infection of different coronaviruses (Keck et al., 
1987; 1988a; 1988b; Makino et al., 1986b; 1987). In the mixed infection, viral 
RNA transcription intermediates may dissociate from one template to bind 
to another viral template at the homologous sequence and be incorporated 
into genomic RNA in the subsequent RNA replication. 
The complex viral transcription and replication strategy of 
coronavirus indicates a viral RNA polymerase with unusual properties. 
Murine coronavirus polymerase polyprotein 
The coronavirus encoded RNA polymerase is known to be 
responsible for replication of the viral negative RNA, synthesis of genomic · 
and subgenomic RNAs, and replication of virion RNA (Brayton et al., 1982; 
1984; Lai et al., 1982b; Leibowitz et al., 1982a). In addition, coronavirus 
polymerase is also known to transcribe the small leader RNAs which have 
been detected in the coronavirus infected cells (Lai et al., 1983; 1984; Barie et 
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al., 1983). To better understand the functional activities of coronavirus 
polymerase, we must elucidate the mechanism of MHV RNA polymerase 
expression and processing. 
The murine coronavirus RNA polymerase is encoded by the 5' most 
gene of the virion RNA, termed gene 1. Gene 1 has been completely 
sequenced for coronavirus IBV (Bournell et al., 1987), MHV-JHM (Lee et 
al., 1991), MHV-A59 (Pachuk et al., 1989; Bredenbeek et al., 1990; Bonilla et 
al., 1994) and HCV (Herold et al., 1993). In the MHV-JHM virus strain, 
gene 1 is 22 kb in length and encompasses about two thirds of the entire 
viral genome (Lee et al., 1991). This gene is known to contain two 
overlapping open reading frames designated ORFla (13 kb) and ORFlb (9 
kb) which can be translated into a single polyprotein greater than 750 kDa 
via a ribosomal frameshifting mechanism (Brierly et al., 1987; 1989; 
Bredenbeek et al., 1990; Lee et al., 1991). Computer analysis of the deduced 
amino acid sequence of this large polymerase polyprotein suggests diverse 
functional domains, such as a polymerase motif, a helicase domain, a zinc-
finger motif in ORFlb, transmembrane regions, cysteine-rich domains, 
and three proteinase domains in ORFla (Gorbalenya et al., 1989; 1991; 
Bredenbeek et al., 1990; Lee et al., 1991) (see Fig. 2). The three proposed 
proteinase domains, two papain-like cysteine proteinases (PCP-1 and PCP- · 
2) and a poliovirus 3C-like serine proteinase (3C-Pro), are approximately 
3.5-4.2 kb, 5.3-6.l kb, and 10.2-10.9 kb from the 5' end of the gene 1 
respectively (Lee et al., 1991). The large size of the polymerase polyprotein 
and the presence of potentially active proteinase domains suggest that the 
8 
Fig. 2. Schematic diagram of murine coronavirus gene 1 and its putative 
functional domains. (The figure was modified from Lee et al., 1991). 
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putative polymerase polyprotein undergoes extensive proteolytic processing 
to release multiple mature and functional protein products. 
Prote<>]ytic processing of the murine coronavirus polymerase polyprotein 
Since gene 1 is expressed at a very low level and coronavirus does not 
inhibit host cell protein synthesis efficiently, it is very difficult to investigate 
viral gene expression in vivo without specific antibodies. Early studies of 
gene 1 translation products were mainly done in the rabbit reticulocyte 
lysate (RRL) cell free protein-synthesizing system (Leibowitz et al., 1982b; 
Denison and Perlman, 1986). The first protein to be identified as a 
proteolytic processing product of the polymerase polyprotein was a 28 kDa 
protein, designated p28. Denison and Perlman (1986) demonstrated that in 
vitro translation of MHV-A59 genomic RNA isolated from virus-infected 
cells produced two prominent proteins, p28 and p220 (Denison and 
Perlman, 1986). The appearance of p28 could be inhibited by the addition of 
the proteinase inhibitor ZnCl2, suggesting that p28 was processed from a 
precursor polyprotein (Denison and Perlman, 1986). p28 was shown to be 
the N-terminal peptide processed from the gene 1 polyprotein and also 
detected in MHV infected cells (Denison and Perlman, 1986; 1987). By in 
vitro T7 RNA polymerase transcription and in vitro translation in rabbit · 
reticulocyte lysates of a plasmid containing the 5'-end 2 kb cDNA of gene 1, 
p28 was confirmed as the amino-terminal portion of the putative 
polymerase polyprotein (Soe et al., 1987). Furthermore, by translating 
RNAs which represented up to 5.3 kb of the 5'-end of the MHV genome, 
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Baker et al. showed that the processing of p28 was an autoproteolytic event 
in which a downstream sequence about 4 kb from the 5' end of gene 1 was 
required for the cleavage of p28 (Baker et al., 1989). Significantly, this 
region overlaps with the first papain-like cysteine proteinase (PCP-1) 
domain predicted from sequence analysis (Gorbalenya et al., 1991, Lee et 
al., 1991), suggesting that PCP-1 is the proteinase which cleaves the p28 
protein. 
In addition to p28, several other protein products ranging from 50 
kDa to 290 kDa in size have been detected from the in vitro translation of 
MHV genomic RNA or in the infected cells using antiserum directed 
against viral peptides or fusion proteins (Denison et al., 1991; 1992). 
However, the proteinases responsible for their processing are largely 
unknown. Our knowledge of how these proteins are processed from the 
polymerase polyprotein and the relationships between them is also 
incomplete. Currently, the first papain-like cysteine proteinase (PCP-1) is 
the only proteinase domain among the three proposed proteinases whose 
activity has been directly demonstrated (Baker et al., 1989). Although the 
only known function of PCP-1 is to mediate a cis-cleavage of p28, it is highly 
possible that PCP-1 cleaves at additional sites in the coronavirus 
polymerase polyprotein. The study of p28 processing will enrich our 
knowledge of proteolytic processing of the polymerase polyprotein and help 
to predict additional processing events. 
12 
The proteolytic processing of the polymerase polyprotein may play an 
important role in regulating viral replication, as has been shown in several 
other viruses such as poliovirus and Sindbis virus (Dewalt and Semler, 
1987; Lemm and Rice, 1993; Shirako and Strauss, 1994). In addition, 
proteolytic processing may activate diverse functions of the polymerase 
polyprotein by inducing conformational changes. In terms of the 
understanding of how coronavirus polymerase works, it is possible that the 
polymerase polyprotein undergoes proteolytic cleavages at several sites to 
release multiple functional units. The functional subunits may still 
associate together as a working complex for coronaviral RNA replication. 
Understanding the proteolytic processing of gene 1 may ultimately help us 
to identify individual polymerase subunits and to understand their 
functions. Additionally, viral proteinases are potential targets for specific 
antiviral agents since viral replication can be interrupted by inhibiting the 
essential proteolytic processing events to inactivate fundamental enzymes 
for viral replication. Such work has already begun for human 
immunodeficiency virus (HIV), and results suggest that intervention with 
proteinase inhibitors may become a successful treatment for Acquired 
Immune Deficiency Syndrome (AIDS) (McQuade et al., 1990). 
The goal of this Ph.D. dissertation research is to study proteolytic 
processing of the murine coronavirus polymerase polyprotein, especially 
focusing on the p28 processing event. Previous studies lead to the 
hypothesis that the MHV PCP-1 proteinase domain, which acts to cleave at 
the amino terminal region of polymerase polyprotein to release p28, 
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probably belongs to the family of cysteine proteinases (with plant proteinase 
papain as the prototype). The following questions were addressed in this 
research: 1) What are the catalytic residues of MHV PCP-1? 2) What is 
the cleavage site recognized by MHV PCP-1 to release p28? 
To address these questions, I have used the well developed T7 RNA 
polymerase transcription/RRL translation system to express a variety of 
mutant polyproteins, and I have assayed the effect of these mutations on 
proteolytic processing of p28. I have characterized the proteinase activity 
and the catalytic sites, showing that PCP-1 is a new member of the family of 
papain-like cysteine proteinases. Additionally, I have identified the 
cleavage site by partial N-terminal protein sequencing, and defined the 
recognition motif of the cleavage site by site-directed mutagenesis. 
p]aSJDid DNA 
CHAPrERD 
MATERIALS AND METHODS 
A T7 RNA polymerase transcription plasmid pT7-NBgl, which 
contains the MHV-JHM genomic cDNA sequence from nucleotide 187 (Nar 
I site) to 5273 (Bgl II site), and its deletion plasmids pT7-NAc, pT7-N27 and 
pT7-N29 have been previously described (see Fig. 3, Baker et al., 1989; 1993). 
pT7-NAc is derived from pT7-NBgl with a deletion from nucleotide 4434 
(Ace I site) to 5273 (Bgl II site). pT7-N27 is derived from pT7-NAc with a 
deletion from nucleotide 2068 (Nsi I site) to 2811 (Kpn I site ). T7-N29 is 
derived from pT7-NAc with deletion from nucleotide 1167 (SnaB I site) to 
2811 (Kpn I site). 
Plasmid DNA preparation 
Large scale preparations and minipreparations of plasmid DNAs 
were isolated by the alkaline lysis method basically as described by Maniatis 
et al. (1982). For large scale plasmid preparation, a single colony was 
inoculated into 5 ml Luria broth (LB, lOg/l bacto-tryptone, 5g/l bacto-yeast 
extract and lOg/1 NaCl, pH 7.0) with 50 mg/ml ampicillin (Amp) and grown 
for 5-6 hours at 37oc with vigorous shaking (250 rpm). Two and one half ml 
of this small culture was inoculated into 250 ml LB/Amp (50 µg/ml) and 
incubated with shaking for 14-16 hours at 37oc. The bacteria were 
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Fig 3. Schematic diagram of corresponding gene 1 sequence in the 
plasmids of pT7-NBgl family. A partial restriction map of the 5'-end 5.3 kb 
of MHV-JHM genomic cDNA is shown to scale (Nar 1:187, SnaB 1:1167, Nsi 
1:2068, Kpn 1:2811, Ace 1:4434, Bgl 11:5273). The translation initiation codon 
(AUG) is at nucleotide 215. The p28 region, which is released by the 
autoproteinase activity, is denoted by the stippled box. The putative first 
papain-like cysteine proteinase (PCP-1) domain is indicated by the hatched 
box. The putative p28 cleavage site at approximately 1 kb from the 5' end is 
indicated by an arrow. The sizes of encoded precursor polyprotein and 
potential processed products are indicated in the parenthesis. 
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harvested by centrifugation at 7 k rpm for 10 min at 4oc in a Sorvall GSA 
rotor. The pellet was resuspended in 4 ml of solution I (50 mM glucose, 100 
mM EDTA, 28 mM Tris-HCl, pH 8.0) and incubated for 15 min at room 
temperature. Bacteria were lysed by adding 7.5 ml of solution II (0.2 N 
NaOH, 1 % SDS, freshly made from 10 N NaOH and 10% SDS), and 
incubated for 10 min on ice. The cell lysates were neutralized by adding 6 
ml of solution III (5 M KOAc, pH 4.8) and inverting the tubes and incubated 
for 10 min on ice. The cell debris was pelleted by centrifugation for 30 min 
at 12 k rpm at 4oc in a Sorvall SS34 rotor. The supernatant (about 16 ml) 
was transferred to a Corex tube (30 ml capacity), mixed with 0.6 volume (11 
ml) of isopropanol and incubated for 15 min at room temperature. The 
nucleic acids were pelleted by centrifugation for 10 min at 10 k rpm in a 
Sorvall SS34 rotor and the pellet was dried in a Savant Speed Vac. This 
nucleic acid pellet was resuspended in 8 ml of TE buffer (10 mM Tris-HCl, 1 
mM EDTA, pH 8.0) and treated with 40 µl RNase A (10 mg/ml stock 
solution) for 30 min at 42oc to degrade tRNA (transfer RNA). The 
supercoiled plasmid DNA was purified by equilibrium centrifugation in 
cesium chloride (CsCl) ethidium bromide gradients. For each ml of DNA 
solution, 1 g of solid CsCl was added and the final density of the solution 
should be 1.55 g/ml (refractive index= 1.3860). When the salt is completely 
dissolved, 250 µl ethidium bromide (10 mg/ml stock solution, final · 
concentration 312.5 µg/ml) was added. The mixed sample was centrifuged 
for 14-16 hours at 55 k rpm in a Beckman VTi 65 rotor. The band of the 
supercoiled plasmid DNA was collected by side puncture with a 16 gauge 
needle. The ethidium bromide was removed from the DNA by repeated 
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extraction with an equal volume of deionized water-saturated butanol until 
the pink color disappeared. The CsCl was removed by overnight dialysis at 
40C with at least two changes of 0.5 X TE buffer. Finally, the DNA solution 
was collected and stored at 4oc. The yield and purity of plasmid DNA was 
determined by measuring OD at 260 nm and OD at 280 nm in a UV 
spectrophotometer. The plasmid DNA was analyzed by electrophoresis in a 
1 % agarose gel. The DNA (0.2 µg) was diluted in 6 X loading buffer (0.25% 
bromophenol blue, 0.25% xylene cyanol FF and 30% glycerol) and loaded 
onto a 1 % mini-agarose gel prepared in 1 X TBE buffer (89 mM Tris-HCl, 89 
mM boric acid, 2 mM EDTA, pH 8.0) containing 0.5 µg/ml ethidium. 
bromide. The DNA was analyzed by electrophoresis at 100 Volts (V) for 30 
min. Lambda DNA digested with Hind III (Gibco BRL) was loaded as the 
size marker. 
Minipreparations of plasmid DNA were carried out using the 
Magic™ Minipreps DNA Purification System (Promega) following the 
manufacturer's instructions. Briefly, 3-5 ml of the overnight cultured 
bacteria cells were pelleted in an Eppendorf microcentrifuge (1 min at high 
speed) and the pellet was resuspended in 200 µl of Cell Resuspension 
Solution (Sm mM Tris-HCl, pH 7.5, 10 mM EDTA, pH 8.0, 100 µg/ml RNase 
A). The cells were lysed by adding 200 µl of Cell Lysis Solution (0.2 M · 
N aOH, 1 % SDS) and inverting the tube several times. To the cell lysates, 
200 µ:1 of Neutralization Solution (2.55 M KOAc, pH 4.8) was added and 
mixed by inverting the tubes. After centrifugation for 5 min at 12,000 X g, 
the supernatant was transferred to another tube and mixed with 1 ml of the 
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in 5 mM EDTA and 0.5% SDS for 30 min at 56°C to digest the restriction 
enzymes. The final volume was brought up to 200 µl with dH20 and the 
linearized plasmid DNA was extracted with an equal volume of 
phenol:chloroform (1:1) once and then an equal volume of 
chloroform:isoamyl alcohol (24:1) once. Eight µl of 5 M NaCl (final 
concentration 200 mM) and 2.5 volume of ethanol were added to the 
supernatant and mixed by vortexing. The mixture was frozen at -700C for 
20 min and centrifuged for 10 min at 12,000 X g to precipitate DNA. The 
DNA pellet was gently rinsed with 1 ml of cold 70% ethanol and dried in a 
Savant Speed Vac. The final DNA pellet was resuspended in 20 µl of DEPC-
dH20 (diethyl pyrocarbonate treated nuclease-free water) and 2 µl was 
removed for analysis by electrophoresis on a 1 % mini-agarose gel as 
described above. 
In vitro T7 RNA polymerase transcription 
Plasmid DNA was transcribed in vitro with a T7 RNA polymerase 
(Promega) specific for a T7 promoter (Tabor and Richardson, 1985). The 
transcription reaction was performed in a total volume of 50 µl with 1 µg of 
linearized plasmid DNA in 40 mM Tris-HCl (pH 7 .9), 6 mM MgCl2, 10 mM 
DTT (dithiothreitol), 2 mM spermidine, 10 mM NaCl, 0.5 mM of ATP, CTP, 
and UTP, 0.05 mM GTP, 0.25 mM m7G(5')ppp(5')G cap analog (NEB), 10 u 
of T7 RNA polymerase (Promega), and 40 u of RNasin ribonuclease 
inhibitor (Promega) and DEPC-dH20 at 37oc for 1 hour (Baker et al. 1989; 
1993). The reaction mixture was treated with 2 u of RQI DN ase (Promega) 
at 37oc for 30 min to degrade the DNA template. The final volume was 
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brought up to 200 µI with DEPC-H20 and extracted with an equal volume of 
phenol:chloroform (1: 1) and then an equal volume of chloroform:isoamyl 
alcohol (24:1). The upper aqueous phase was transferred to a sterile 
microcentrifuge tube and mixed with 0.1 volume of 3M NaOAc and 2.5 
volume of ethanol and cooled to -700C for 20 min. The mixture was 
centrifuged at 12,000 X g for 10 min. The pellet (normally milky white) was 
gently rinsed with 1 ml of cold 70% ethanol, dried and resuspended in 100 µl 
DEPC-H20. The resuspension solution was mixed with 100 µl 5M NH40Ac 
(final concentration 2.5 M) and 2.5 volumes of ethanol and frozen for 20 min 
at -700C. This second precipitation removes free nucleotides. The final 
pellet was gently rinsed in cold 70% ethanol, dried in a Savant Speed Vac 
and resuspended in 20 µl of DEPC-dH20. The yield was quantitated by 
measuring OD at 260 nm in a UV spectrophotometer. Two µl of RNA was 
diluted in 6 X loading buffer and analyzed in a 1.2% agarose gel (prepared 
in filtered 1 X TBE buffer containing 0.1-0.5 µg/ml ethidium bromide) at 60 
V for 1-2 hour(s) (See Fig. 4). Lambda DNA Hind III fragments were 
loaded as the size marker. The remaining RNA was stored at -700C until 
future use. 
In vitro translation in rabbit reticulocyt.e lysates 
Translation of in vitro transcribed RNA by T7 RNA polymerase was 
performed in the nuclease treated rabbit reticulocyte lysates following 
manufacturer's suggestion (Promega). Two hundred ng of purified RNA 
transcripts were mixed with 10 µl of the nuclease treated rabbit reticulocyte 
lysates, 1 µl of 1 mM amino acid mixture (minus Met) and 2 µl of 35S-Met 
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Fig. 4. Agarose gel electrophoresis analysis of the in vitro transcribed pT7-
N27 RNA. Plasmid pT7-N27 linearized with EcoR I was transcribed by a T7 
RN A polymerase from a specific T7 promoter as described in the Materials 
and Methods. RNA from four standard reactions was combined and 2 µl 
RNA (approximately 200 ng) was analyzed by electrophoresis in a 1.2% 
agarose gel and visualized by staining with ethidium bromide. Lambda 
DNA digested with Hind III was used as the size marker. 
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'1,000 µCi/ml, Amersham) or Trans 35S-label (1,000 µCi/ml with 70% 35g_ 
( 
r Met and 15% 35S-Cys, ICN) and DEPC-dH20 in a final volume of 25 µl and 
incubated for 90 min at aooc. One to two µl of the reaction was diluted in 10 
,u of 2 X Laemmli Sample Buffer (10% glycerol, 5% fi-mercaptoethanol, 3% 
SDS, 80 mM Tris-HCl, pH 6.8, and 1 µg/ml bromophenol blue) (Laemmli, 
1970) and analyzed by electrophoresis in 10% polyacrylamide gel containing 
0.1% SDS. The remainder of the translation reaction was stored at -700C. 
Coupled in vitro transcription and trans1ation 
Linearized plasmid DNA template was transcribed with T7 RNA 
polymerase and translated in rabbit reticulocyte lysates in a coupled 
transcription translation system (TNT lysates, Promega) following the 
manufacturer's protocol. For a standard reaction, approximately 0.5 µg of 
linearized plasmid DNA was incubated with 12.5 µl TNT rabbit reticulocyte 
lysate, 1 µl TNT reaction buffer, 0.5 µl T7 RNA polymerase (Promega), 20 u 
RN asin ribonuclease inhibitor (Promega), 1 µl of 1 mM Met-free amino acid 
mixture, and 2 µl of 35_8-Met (1,000 µCi/ml, Amersham) or Trans 35S-label 
(1,000 µCi/ml, 70% 35S-Met and 15% 35S-Cys, ICN) and DEPC-dH20 in a 
final volume of 25 µl for 90 min at aooc. Two µl of the reaction were 
removed and precipitated by trichloroacetic acid (TCA) to measure 
incorporation of radioactivity. One to two µl of the reaction was analyzed by 
electrophoresis in a 10% SDS polyacrylamide gel and the remainder was 
stored at -700C. 
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TCA precipitation assay to determine incorporation of radioactivity in the 
in vitro translated prot.ein product 
The incorporation of radioactivity into the protein products of an in 
vitro translation was measured by a trichloroacetic acid (TCA) precipitation 
assay (Sambrook et al., 1989). The simplified protocol for TCA protein 
precipitation assay was from Dr. Tom Gallagher (Loyola University of 
Chicago). Individual Whatman 3MM filter paper disks (2-2.3 cm in 
diameter) were spotted with 100 µl of Solution A [3% CAA (casamino acids, 
as a protein carrier), 1 % SDS] and air-dried for 0.5-1 hour. Two µl of the 
translation reaction was loaded at the center of the filter disk and air-dried 
for 10 min. Two µl from an in vitro translation reaction containing no 
mRNA was spotted onto a filter paper disc as a control to determine the 
background incorporation. The sample-loaded filters were transferred into 
a capped plastic tube (50 ml capacity, 4-6 filters per tube) and washed in 45 
ml of Solution B (10% TCA, 3% CAA, 1 % SDS) by slow shaking in an orbital 
shaker for 30 min at room temperature. Solution B and all other used 
solutions containing radioactivity were carefully discarded into a 
radioactive liquid disposal container. Forty-five ml of Solution C (5% TCA, 
1.5% CAA) was added and incubated in an 850C shaking water bath for 20 
min. The filters were washed twice for 5 min with 45 ml of 5% TCA and 
then 45 ml of 95% ethanol. The filters were rinsed twice with dH20 and air-
dried for 0.5-1 hour. Each dried filter was transferred to a 5 ml plastic 
scintillation vial with 4 ml of biodegradable counting cocktail Econo-Safe™ 
(Research Products International Corp.) and counted in a Beckman LS 5801 
scintillation counter using the USER 2 program. The net incorporation of 
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radioactivity in the synthesized protein of each translation reaction was 
calculated by subtracting background from the cpm (count per min). 
Anti-p28 serum and radioimmunoprecipitation 
Polyclonal anti-p28 serum was generated in a rabbit against a 
eynthetic peptide representing amino acids 78 to 93 (NH3-R-D-I-F-V-D-E-D-
P-Q-K-V-E-A-S-T-COOH) of the p28 protein (previously prepared in our 
laboratory, Baker et al., 1989). One and one half g of Protein A-Sepharose 
CL-4B beads (Pharmacia) were swollen in 15 ml of dH20 and washed 2-3 
times in PBS buffer (8 g/l of NaCl, 0.2 g/l KCl, 1.44 g/l N a2HP04 and 0.24 g/l 
KH2P04) to remove any additives and stored at 4oc for future use. To avoid 
the loss of beads during washing, the bead suspension can be briefly 
centrifuged after each step. The desired amount of beads were removed 
prior to each use. The beads were spun down, washed once in RIP A buffer 
(0.5% Triton X-100, 0.1% SDS, 300 mM NaCl, 4 mM EDTA and 50 mM Tris-
HCl) and resuspended 1:1 in RIPA buffer. Samples of the in vitro 
translation reaction containing equivalent amount of TOA-precipitable 
radioactivity (10-15 µl, 0.5-5 X 105 cpm) were incubated with 3 µl of anti-p28 
serum in 1 ml of RIPA buffer in a safe-lock microcentrifuge tube with head-
to-tail rotation at 4oc. Thirty µl of a 1:1 suspension of Protein A-Sepharose 
beads in RIP A buffer was added and the incubation reaction was continued 
for an additional 4 hours at 4oc. The beads were pelleted by a brief (1-2 min) 
microcentrifugation and washed three times with 1 ml of RIP A buffer. The 
washed beads were suspended in 50 µl of 2 x Laemmli sample buffer, 
heated at 10000 for 2 min, and microcentrifuged for 5 min. The 
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supernatant was loaded on a 10% polyacrylamide gel containing 0.1 % SDS 
(SDS-PAGE) for electrophoresis. 
polyacrylamide gel electrophoresis and autoradiograpby 
Direct in vitro translation products or the immunoprecipitated 
proteins of in vitro translation were analyzed by polyacrylamide gel 
electrophoresis as described by Maizel, 1971. A 10% acrylamide, 0.1% SDS 
discontinuous gel was prepared in a Hoefer SE 600 Vertical Slab Unit. 
Twenty ml of 10% resolving gel was prepared by mixing 8.4 ml of dH20, 5.0 
ml of 4 X Lower Buffer (181.7 g/l Tris-base, 0.4% SDS, pH 8.8), 6.6 ml of 
30:0.8% Acrylamide:N, N'-methylene-bisacrylamide, 60 µl of 10% APS 
(ammonium persulfate) and 7.5 µl of TEMED (N, N, N', N'-
tetramethylethyl-enediamine). For 10 ml of 5% stacking gel, 6.65 ml of 
dH20, 1 ml of 50% glycerol, 1.30 ml of 4 X Upper Buffer (60.6 g/l, 0.4% SDS, 
pH 6.8), 1.10 ml of 30:0.8% acrylamide:N, N'-methylenebisacrylamide, 75 µl 
10% APS, and 20 µl of TEMED were mixed together. The gel was run in the 
1 X Running Buffer (12.0 g/l, Tris-base, 57.6 g/l glycine, 0.1% SDS) at 
constant volts (50-200 V) until the bromophenol blue dye reached the bottom 
of the gel. Following electrophoresis, the gel was removed and fixed for 30-
60 min in 40% methanol-7% acetic acid solution with gentle shaking in an 
orbital shaker. After fixing, the gel was enhanced for 1.5 hours with Du· 
Pont Entensify, dried and exposed to Kodak X-ray film at -700C. 
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p,oteinase inhibition assay 
The proteinase inhibition assay was performed using pT7-N27 RNA 
(see Fig. 4) in rabbit reticulocyte lysates in the presence of a variety of 
proteinase inhibitors. The proteinase inhibitors tested include a general 
inhibitor ZnCl2, four cysteine proteinase inhibitors: cystatin (Boehringer 
Mannheim Biochemica, BMB), Iodoacetamide (Sigma), N-ethyl-maleimide 
(Sigma) and E-64 (BMB), a cysteine and serine proteinase inhibitor 
leupeptin (BMB), a serine proteinase inhibitor APMSF [94-(amidinophenyl)-
methanesulfonylfluoride, BMB], an aspartic proteinase inhibitor pepstatin 
A (BMB), and a metallo-proteinase inhibitor EGTA 
{[ethylenebis(oxyethlenenitrilo)]-tetraacetic acid, BMB}. Large quantities of 
RNA were synthesized in vitro as described in the in vitro transcription 
reaction. Four standard in vitro transcription reactions (50 µl) were set up 
and the final products of each reaction were resuspended in 20 µl of dH20 
and combined together to quantitate the concentration and yield of the RNA 
synthesized. The same amount of homogenized RNA (approx. 200 ng) was 
used in each translation reaction as described in the in vitro translation 
reaction in rabbit reticulocyte lysates. The proteinase inhibitor was added 
to the translation reaction (25 µl, final volume) prior to the incubation at 
300C and the translation reaction was carried out for 90 min. The 
translation products were analyzed by electrophoresis in a 10% SDS- · 
polyacrylamide gel and autoradiography. The radioactivity of p28 (with 7 
Met) and the precursor polyprotein (with 37 Met) was quantitated in a 
Betagen scanner. The efficiency of p28 processing was calculated after 
normalizing the differences in Met contents in the following formula: 37 X 
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[p28] / { 37 X [p28] + 7 X [precursor]}. The percentage of the inhibition was 
measured by comparing the decrease of p28 processing efficiency in the 
translation reaction with proteinase inhibitors to that without proteinase 
inhibitors. A wide range of concentrations of each inhibitor was tested to 
achieve an optimal working concentration. The optimal concentration 
produced significant inhibition of p28 processing but had no effect on the 
overall efficiency of translation reactions. 
Purification of DNA from low-melting agarose gels 
Low-melting agarose gel (SeaKem, FMC) with 1 cm wide wells were 
prepared in 1 X TAE (40 mM Tris-acetate, 1 mM EDTA) containing 0.1 
µg/ml ethidium bromide. Restriction enzyme digested plasmid DNA was 
loaded onto the gel, fragments were separated by electrophoresis at 60 V for 
3-4 hours and visualized on an ultraviolet light transilluminator. The 
specific DNA bands of interest were identified according the DNA marker 
(lambda DNA digested with Hind III fragments, Gibco BRL) and excised 
from the gel with a razor blade. The agarose gel slice containing DNA was 
submerged in 3 volume of TE buffer in one (or several) microcentrifuge 
tube(s) and heated at 1ooc for 2-5 min in a heating block. The melted 
agarose solution was homogenized by briefly vortexing and quickly frozen 
in a dry-ice ethanol bath (-700C) for 5-10 min. The mixture was thawed by· 
tapping the tube vigorously against the lab bench. The solidified agarose 
beads were removed by centrifugation for 1-5 min. The agarose-free DNA 
in the supernatant was extracted with equal volumes of phenol:chloroform 
and chloroform:isoamyl alcohol and concentrated by ethanol precipitation. 
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The DNA pellet was washed with cold 70% ethanol and resuspended in 20 
µl of TE buffer. 
Construction of plasmid pS-N27 
For site-directed mutagenesis, the MHV-JHM gene 1 sequence in 
pT7-N27 was inserted into plasmid pSELECT-1 (Altered Sites in vitro 
Mutagenesis System, Promega) to create a new recombinant plasmid pS-
N27 (see Fig. 5). pSELECT-1 (Amps and Teer), a hybrid of pBR322 and 
pGEM-3Zf{+), carries modified ampicillin gene (4 base frameshifting), a 
tetracycline resistance gene, a fl replication origin and a polylinker region 
(Lewis and Thompson, 1990). Plasmid pT7-N27 contains MHV-JHM 
genomic cDNA sequence from nucleotide 187 to nucleotide 4434 with a 747 
nucleotide deletion of nucleotide 2064-2810 under the control of a T7 
promoter. This 3.5 kb region of gene 1 (with a translation start codon at 
nucleotide 215) has a capacity to encode a 128 kDa precursor polyprotein 
which is expected to autoproteolytically release p28 and a 100 kDa C-
terminal protein (Baker et al. , 1993). Four µg of pT7-N27 was digested by 
Pvu II (upstream of the T7 promoter) and EcoR I (just downstream of the 
MHV-JHM region) in a volume of 200 µI. Five µg of pSELECT-1 was 
digested by Sma I and EcoR I (Both sites are located within the polylinker 
region) in a reaction of 200 µl. Completion of each digestion was checked by 
electrophoresis in a 1% agarose gel. The double digested pSELECT-1 DNA 
was extracted with equal volumes of phenol:chloroform (1: 1) and 
chloroform:isoamyl alcohol (24:1) and concentrated by ethanol 
precipitation. The resuspended pSELECT-1/Sma l/EcoR I DNA was 
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Fig. 5. Schematic diagram of MHV-JHM gene 1 cDNA in plasmid pS-N27 
and its encoded polypeptide and autoproteolytically processed proteins. The 
MHV-JHM gene 1 cDNA from an in-frame deletion construct, pT7-N27, 
was inserted into plasmid pSELECT-1 as described in the Materials and 
Methods. The new recombinant plasmid was named as pS-N27 (A). This 
3.5 kb gene 1 clone, containing nucleotides from 187 (Nar I site) to 2063 (Nsi 
I site) and nucleotides from 2811 (Kpn I site) to 4431 (Ace I site), is the 
smallest deletion clone which still maintains active proteolytic processing 
of p28. The two overlapping reading frames (ORF) are shown at the top 
with only ORFla drawn to scale. The three proposed proteinase domains 
(Lee et al., 1991) are indicated, among which PCP-1 (hatched box, between 
3.5-4.2 kb) has been demonstrated to be active (Baker et al., 1989). Proteolytic 
processing of the polypeptide translated from RNA derived from plasmid 
pS-N27 (also pT7-N27) is shown at the bottom (B). The precursor polypeptide 
(128 kDa) synthesized from linearized pS-N27 (also pT7-N27) in the in vitro 
T7 RNA polymerase transcription and rabbit reticulocyte lysate translation 
system is autoproteolytically processed to two products: N-terminal p28 and 
C-terminal peptide (100 kDa) (Baker et al., 1993). The p28 region is 
indicated by the stippled box and PCP-1 domain by the hatched box. The 
arrow represents the putative cleavage site of p28. 
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further de-phosphorylated by calf intestinal alkaline phosphatase (CIP, 
BRL) in 1 mM ZnCl2, lmM MgCl2, and 10 mM Tris-HCl, pH 8.3. CIP was 
removed by protease K treatment in 5 mM EDTA and 0.5 % SDS, and 
extracted with equal volumes of phenol:chloroform (1:1) and 
chloroform:isoamyl alcohol (24:1). The double digested pT7-N27 and 
pSELECT-1 (de-phosphorylated) were respectively separated by 
electrophoresis in a 1.2% or 0.8% low-melting agarose gel. The insert (a 3.5 
kb DNA fragment of pT-N27) and the vector (a 5.6 kb DNA fragment of 
pSELECT-1) were purified from the low-melting agarose gels by the freeze 
and thaw method as described above. The gel purified fragments were 
ligated in a volume of 10-20 µl with 1 u ofT4 DNA ligase (BRL), 50 mM Tris-
HCl pH 7.6, 10 mM MgCl2, 1 mM ATP and 1 mM DTT at 14oc for 8-16 
hours. The control for the ligation reaction contained only CIP-treated 
vector but no insert. An E. coli DH5a strain was transformed by the 
ligation reaction and spread on a LB plate containing tetracycline (15 
µg/ml), X-Gal (5-bromo-4-chloro-3-indolyl-~-D-galactoside, 40 µl of 20 mg/ml 
per plate) and IPTG (isopropylthio-~-D-galactoside, 4 µl of 200 mg/ml per 
plate). Only the white colonies were isolated to screen the recombinant 
plasmid, and the recombinant plasmid pS-N27 was confirmed by restriction 
enzyme digestion. 
Single-strand phagemid DNA preparation 
Phagemid pS-N27 containing a fl origin (which is derived from a 
filamentous bacteriophage) can replicate in a single strand form in E. coli 
strain JM109 after infection with helper phage R408 (Vieira and Messing, 
34 
1987; Maniatis et al., 1982). JM109 were transformed with p8-N27 and 
spread on a minimal plate {3g/l KH2P04, 7 g/l K2HP04, 2 g/l (NH4)2804, 0.5 
mg/l Fe804, 10 mM Mg804, 0.05 mg/l thiamine, and 4% glucose) 
containing tetracycline (15 µg/ml) to ensure the presence of bacterial Fl pill 
for bacteriophage infection. A single tetracycline-resistant colony of JM109 
containing p8-N27 plasmid was inoculated in 5 ml of TYP broth (16 g/l 
Bacto-tryptone, 16 g/l Bacto-yeast extract, 5 g/l NaCl and 2.5 g/l K2HP04) 
with 15 µg/ml tetracycline in a 50 ml tube to prepare an overnight culture. 
Two hundred µl of the overnight culture was inoculated into 5 ml of TYP 
broth containing 15 µg/ml tetracycline in a 125 ml flask with vigorous 
shaking for 30 min at 37oc. The culture was infected with helper phage 
R408 at an m.o.i. (multiplicity of infection) of 10 (40 µl of the stock from 
Promega, >1 X 1011 plaque forming unit per ml or pfu/ml) and shaken for 
additional 6-8 hours. The bacteria were pelleted by centrifugation twice at 
10 k rpm for 5 min at 40C in a 8orvall 8834 rotor. The supernatant 
containing the secreted phage particles was transferred to a Corex tube (15 
ml), mixed gently with 1/4 volume of phage precipitation solution (3.75 M 
NH40Ac and 20% PEG) and incubated on ice for 15-30 min. The mixture 
was centrifuged at 10 k rpm for 15 min at 4oc. The pellet was drained 
thoroughly and then resuspended in 400 µl of TE buffer. The suspended 
solution was transferred to a microcentrifuge tube and extracted by equal 
volumes of chloroform (first, to lyse the phage particles), phenol:chloroform 
(1:1, twice), and then chloroform:isoamyl alcohol (24:1). The upper aqueous 
phase was transferred to sterile microfuge tubes and mixed with 0.5 
volume of 7.5 M NH40Ac, 2 volumes of ethanol and frozen at -700C for 20 
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min. Single-strand DNA (phage R408 DNA and single-stranded pS-N27) 
was precipitated by centrifugation at 10 k rpm for 15 min at 4oc. The pellet 
was rinsed with cold 70% ethanol, dried in a Savant Speed Vac and 
resuspended in 20 µl of dH20. Two µl of the final product was checked by 
electrophoresis in a 0. 7% mini-agarose gel prepared in 0.5 X TBE 
containing 0.25 µg/ml ethidium bromide at 20 V overnight or at 50 V for 2-4 
hours (see Fig. 5). Ml3mpl8 DNA (7.25 kb, from the USB sequencing kit) 
and Lambda DNA Hind III fragments were loaded as the marker. The 
molar concentration of the single-stranded DNA was roughly estimated by 
measuring OD at 260 nm in a UV spectrophotometer. 
Oligonucleotid.e synthesis and phosphorylation 
Mutagenic oligonucleotides were synthesized by Dr. Basam Wakim 
at Loyola University Medical Center. Degenerate oligonucleotides listed in 
Table 1 were used for site-specific mutagenesis of the putative catalytic 
residues Cys-1137 and His-1288, and two control residues Cys-1172 and His-
1317. Degenerate oligonucleotides listed in Table 2 were used for site 
specific mutagenesis at the identified cleavage sites and its flanking 
sequences (according to the nomenclature of Schechter and Berger, 1967) 
including residues Arg-243 (P5), Gly-244 (P4), Tyr-245 (P3), Arg-246 (P2), 
Gly-247 (Pl) Val-248 (Pl'), Lys-249 (P2') and Pro-250 (P3'), and also at the 
previously suggested cleavage site Tyr-257 and Gly-258 (Soe et al., 1987). 
These oligonucleotides contained degenerate sequences at positions which 
would result in amino acid substitutions at specific residues of the MHV-
JHM polymerase polyprotein. A forward primer B67 (5'-
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Fig. 6. Agarose gel electrophoresis analysis of single-strand pS-N27 DNA. 
Single-strand pS-N27 DNA (lanes 1and2) was prepared as described in the 
Materials and Methods and analyzed by electrophoresis in a 0.7% agarose. 
gel. Lambda DNA Hindlll fragments (lane M) and wild type bacteriophage 
M13mp18 (lane M13, 7.25 kb) were used as the size markers. Single-
stranded pS-N27 DNA (9.3 kb) and helper phage R408 DNA (6.4 kb) are 
indicated. 
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TableL 
Wild-type 
Amfnoacld 
Cys-1137 
His-1288 
His-1317 
Cys-1172 
OJigonucleotides used to generate sit.e specJfic mutations 
in the MBVPCP-1 protelnaae domafn.. 
Mutagenic Mutation 
oligonu.cleotide (IS' to 3')* Qxbi Amino Acid 
CGCAGCCAXXXA.TTAGTACGC TAT Tyr 
CGT Arg 
AGT Ser 
GGT Gly 
TGG Trp 
GCCATAG.AXXXGCAATCATT ACA Thr 
CGT Arg 
GTCATACC~CCCACCAT CAG Gln 
GTG Val 
TCT Ser 
CCG Pro 
CCACAAAGXXTTGATCATAGCC AAC Asn 
TCC Ser 
-·-'1-'iB-.t 4kQ 
w 
00 
Table 2. Oligonucleotides used for site-directed mutagenesis of MHV-llIM p28 cleavage site and :flanking 
amino acid sequence. (to be continued on the next page) 
~tfon8f'1 =tution ( s etter Code) =t on Mutagenic oligonucleotide (S' to 3') • 
Gly-247 (Pl) Ala (A) GCT AGGGOCTATCGCATTGTTAAG 
Asp (D) GAT GA 
Val (V) GTT c 
~~ AAT Arg-246 (P2) CCC CTTAGGGGCTATCCCGGTGTTAAG 
Leu (L) ere TT 
His (H) CAC A 
Ser (S) TCC CTTAGGGGCTATTCCGGTGTTAAGC 
Tyr (Y) TAC T 
A 
Tyr-24S (P3) Arg (R) CGT CTTAGGGGCCCTCGCGGTGTTT 
Ser (S) TCT TT 
Phe (F) TTT G 
Cys (C) TGT 
~ ~\ CCI' Gly-244 (P4) GCC GCTCTTCTTAGGAC CTATCGCGGTGT 
Val (V) GTC GT 
Asp (D) GAC A 
Tyr (Y) TAC GCTCTTCTTAGGTCCTATCGCGGTGT 
Phe (F) TTC CT 
Ser (S) TCC A 
Leu (L) ere 
His (H) CAC 
Arg-243 (PS) Lys (K) AAA GCTCTTCTTAAAGGCTATCGCGGA 
Ile (I) ATA GT 
Thr (T) ACA c 
Ala (A) GCA 
w 
\0 
-~,,,~ 
Table 2. Oligonudeotides used for site-dhec:ted mutasenesis of MHV-JHM p28 cleavage site and flanking 
amino acid sequence. (continued) 
-~~ =· \~u ~:~t.\ = Mutagenic oligonucleotide (5' to 3' • 
Val-248 (Pl' Ala (A) OCT GGCTATCGCGGT AATAAOCCC 
Asp (D) OAT GC 
Oly (G) GOT G 
Ser (S) AOT 
~~ ACT C.Ai GGCTAiCGCGGiCAiMOCJX 
Arg (R) COT TG 
Leu (L) CTT T 
Phe (F) TIT 
Lys-249 (P2' Ala (A) GOO TCGCGGTGTIGGGCCCATCCTG 
Arg (R) AGO AT 
Met (M) ATO c 
Thr (T) ACO 
Pro-250 (P3' Arg (R) CGC TCGCGGTGTIAAOTGCATCCTGTI 
His (H) CAC CA 
Leu (L) ere T 
Tyr-257 (*) Leu (L) CTT GTGGACCAOCTTGOTIGCGAC 
Cys (C) TOT TG 
Arg (R) COT G 
Phe (F) TIT 
Oly-258(•) Ala (A) OCT GOACCAGTATGATTGCGACTATAC 
Asp (D) OAT TC 
* Tyr-257 and Oly-258 dipeptide bond was previously predicted to be the p28 cleavage site (Soe et al, 1987). 
• The complimentary sequences of mutagenic oligonucleotides are shown with degenerate sequences in bold. 
.$)o. 
0 
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GGTAACAAAGGGTCTGTG-3', nucleotide 799 to 817 of MHV-JHM) was 
synthesized for DNA sequencing at the putative cleavage site. These 
synthesized oligonucleotides (approx. 0.2 µmole, as dry powder) were 
resuspended in 500 µl of dH20 and quantitated by measuring OD at 260 nm 
in a UV spectrophotometer. The mutagenic oligonucleotides are 
phosphorylated at the 5' end by T4 polynucleotide kinase to increase the 
ligation efficiency. One hundred picomole of the diluted mutagenic 
oligonucleotide was incubated with 5 u of T4 kinase in 50 mM Tris-HCl, pH 
7.5, 10 mM MgCl2, 5 mM DTT, 0.1 mM spermidine and 1 mM ATP in a total 
volume of 25 µl at 37oc for 30 min. The reaction was heated at 700C for 10 
min to inactivate the kinase and stored at -2ooc until use. 
Site-directed mutagenesis reaction 
Site directed mutagenesis of pS-N27 was based on a coupled 
annealing of the desired mutagenic oligonucleotide and another Ampr 
oligonucleotide to the single-strand DNA templates (see Fig. 7) (Hutchison 
et al., 1978; Lewis and Thompson, 1990). The single-strand pS-N27 DNA 
served as the template for the site specific mutagenesis reaction. One and a 
quarter picomole of one of the phosphorylated synthetic mutagenic 
oligonucleotides (listed in Table 1 and Table 2) was annealed to 0.05 
picomole of the single-stranded pS-N27 in conjunction with 0.25 picomole of 
an Ampr oligonucleotide in 20 mM Tris-HCl, pH 7 .5, 10 mM MgCl2 and 50 
mM NaCl in a 20 µl reaction at 700C for 5 min and then cooled slowly. To 
the annealing reaction, 1 µl of T7 DNA polymerase (10 u/µl, Promega), 1 µl 
of T4 ligase (2 u/µl, Promega), 3 µl of the 10 X Synthesis Buffer (100 mM 
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Fig. 7. Schematic diagram of Altered Sites in vitro mutagenesis procedure 
(from the Promega protocol book). pS-N27 constructed as described in the 
Materials and Methods is the recombinant plasmid here, in which the 
insert (about 3.5 kb) is the MHV-JHM gene 1 cDNA from the plasmid pT7-
N27. Single-stranded pS-N27 DNA was prepared as described in the 
Materials and Methods and used as the template for a mutagenic reaction. 
A mutagenic oligonucleotide, containing mutations at the MHV gene 1 
region (see Table 1 and 2), was annealed to the single-stranded pS-N27 DNA 
in conjunction with Ampr-oligonucleotide which can restore ampicillin 
resistance to the mutated plasmid. The plasmid DNA was synthesized by 
T4 DNA polymerase and ligated by T4 ligase. The ligated DNA was 
transformed into E.coli repair-deficient strain BMH 71-18 mut Sand then 
JM109 which were subjected to ampicillin selection. The amplified mutant 
plasmids were screened by direct DNA sequencing of the desired region. 
Amp8 
~ Amp I 
oligo t 
Amp r l 
l 
l 
l 
Recombinant ssDNA 
template (Amp•, Tet r) 
1 . Anneal ampicillin repair 
oligo and mutagenic oligo. 
2. SY.nthesize mutant strand 
with T 4 DNA polymerase 
and ligate. 
3. Transform BMH 71-18 
mut S. Grow in media + 
ampicillin. 
4. Prepare mini-prep DNA. 
5. Transform JM109. Select 
mutants on ampicillin plates. 
6. Screen for mutants by 
direct sequencing. 
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Tris-HCl, pH 7.5, 5 mM deoxynucleotide mixture with equal dATP, dGTP, 
dCTP, and dTTP and 5 µl of dH20 was added and incubated at 37oC for 90 
min for the minus-strand plasmid DNA synthesis. The ampicillin repair 
oligonucleotide restores ampicillin resistance to the vector and the linking 
of it to MHV-JHM gene 1 mutagenic oligonucleotides allows powerful 
selection of mutants. A repair deficient E. coli strain (BHM71-18 mutS, 
Promega) was transformed by the ligated DNA in a mutation reaction (30 µl 
total). The bacteria were shaken in 0.5 ml of SOC medium (20 g/l Bacto-
tryptone, 5 g/l Bacto-yeast extract, 0.5 g/l NaCl, 2.5 mM KCl, 10 mM MgCl2 
and 20 mM glucose) for one hour at 37oc. Five ml of TYP broth containing 
125 µg/ml ampicillin was added for an additional 8-14 hours of shaking to 
amplify bacteria harboring mutant plasmids. Plasmid DNA was isolated 
from BHM71-18mutS cells and an E.coli strain JM109 was transformed by 
these mutated plasmid DNA. Individual ampicillin resistant colonies were 
isolated to inoculate a 5 ml overnight culture with TYP broth containing 125 
µg/ml ampicillin for minipreparations of plasmid DNA. The prepared 
plasmid DNA was sequenced across the region encompassing the 
degenerate oligonucleotide binding site by double-stranded DNA sequencing 
(USB Sequenase Version 2.0) to screen the desired mutants. 
Plasmid DNA sequencing 
Plasmid DNA sequencing was performed on the basis of Sanger's 
dideoxynucleotide-mediated chain termination reaction using T7 DNA 
polymerase (Sanger et al., 1977). Briefly, 2-3 µg of the double-stranded 
plasmid DNA was denatured in 0.2 M NaOH, concentrated by ethanol 
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precipitation and resuspended in 7 µl of dH20. One half pmol of the 
sequencing primer was annealed to the single-strand pS-N27 DNA in a 20 
µl reaction containing 40 mM Tris-HCl, 20 mM MgCl2, 50 mM NaCl, at 65-
7ooc for 5 min and slowly cooled to sooc. The DNA synthesis was carried 
out using 2 u of T7 DNA polymerase (freshly diluted to 1 u/µl, USB 
Sequenase Version 2.0) for 2-5 min at room temperature after adding 1 µI of 
0.1 M DTT, 2 µl of labeling mixture (freshly diluted to 1.5 µM of dGTP, 1.5 
µM of dCTP, 1.5 µM of dTTP), 0.5 µl of 35S-dATP (10 µCi/µl, NEN). The 
extended DNA product was labeled with 35S-dATP. Two and one half µl of 
the chain extension reaction was randomly terminated by adding 3.5 µl of 
each dideoxynucleotide (8 µM of ddGTP, or ddATP, or ddCTP, or ddTTP, in 
80 µM of four dNTP and 50 mM NaCl) and incubated at 37oc for 5 min. The 
sequencing reaction was stopped by adding 4 µl of Stop Buffer (95 % 
formamide, 20 mM EDTA, 0.05% bromophenol blue, 0.05% xylene cyanol 
FF). The reaction was analyzed by electrophoresis in a 5% polyacrylamide-
7M urea gel (Long Ranger, J. T. Baker). The sequencing gel was 
transferred to a Whatman 3MM paper, dried and exposed to a X-ray film at 
room temperature. (see Fig. 8, a typical sequencing result for screening the 
mutant plasmid) 
Preparation of radiolabeled protein sample and N -terminal 
microsequencing 
To determine the p28 cleavage site, the radiolabeled C-terminal 
cleaved protein product (100 kDa, or plOO) downstream of p28 processed 
from the polyprotein encoded by pT7-N27 was selected for partial N-
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Fig. 8. Autoradiogram of representative sequencing result from screening 
plasmid DNA encoding mutations surrounding the p28 cleavage site. The 
sequencing result of two mutants: Ml (Lys) and M2 (Thr), and the wild 
type: Wt (Arg) of Arg-243 at P5 position are shown. The codons for wild type 
and mutants at position 243 are denoted at the left, and sequences of 
nucleotide 932-952 of MHV-JHM gene 1 from the wild type are indicated at 
the right. 
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terminal protein sequence analysis which is based on Edman degradation 
reaction (Matsudaira, 1987; LeGendre and Matsudaira, 1988). To obtain 
significant amounts of in vitro translation products for protein sequencing, 
large scale in vitro translation reactions were performed in a total volume 
of 100 µl using 4.0 µg of pT7-N27 DNA linearized with EcoR I in the 
presence of 80 µCi of 358-Met (Amersham), or 40 µCi 3H-Leu (ICN Biomed.), 
or 40 µCi 3H-Val (ICN Biomed.) for 90 min at aooc. The in vitro translation 
products were mixed with equal volumes of 2 X Laemmli Sample Buffer 
and separated by electrophoresis in a 7.5% SDS-PAGE gel for 24 hours at 50 
V. Following electrophoresis, the translation products were electro-
transferred to Immobilon polyvinylidene difluoride (PVDF) membrane 
(Millipore) at 40 V, 4oc, for 8-16 hours in buffer containing 25 mM tris-base, 
192 mM glycine, 20% (v/v) methanol and 0.01 % (w/v) SDS. The PVDF 
membrane was air-dried and exposed to a Kodak X-ray film at -700C. The 
band of target protein labeled with 358-Met labeled proteins was identified by 
autoradiography and the bands of corresponding proteins labeled with 3ff. 
Leu or 3ff-Val (not visible) were co-localized in parallel to 358-Met labeled 
proteins. These labeled proteins were excised from the membrane and 
subjected to an Applied Biosystem gas-phase sequencer. Partial N-
terminal amino acid sequence analysis was performed by Dr. Basam 
Wakim at Loyola University Medical Center. Radioactivity released from 
each cycle was quantitated by scintillation counting for 10 min in a 
Beckman scintillation counter and then plotted to identify peaks of 
radioactivity. 
r 
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CHAPTER III 
RESULTS 
Coronavirus polymerase is encoded by gene 1 located at the 5' end of 
the viral genome. This gene (22 kb) is translated as a polyprotein with 
multiple functional domains, including two papain-like cysteine proteinase 
domains and one poliovirus 3C-like serine proteinase domain (see Fig. 2) 
(Lee et al., 1991). These proteinases are proposed to proteolytically process 
the polymerase polyprotein into mature and functional protein products. 
An autoproteinase in the MHV-JHM polymerase polyprotein was shown to 
be responsible for the cleavage of the amino-terminal peptide, p28 (Baker et 
al., 1989). Computer-assisted amino acid sequence searches revealed that 
this autoproteinase overlapped the putative first proteinase domain (PCP-1), 
which has some sequence homology to the cellular cysteine proteinases 
(Gorbalenya et al., 1991). The objective of the research reported in this 
dissertation was to characterize the first papain-like cysteine proteinase 
domain (PCP-1) and to identify the p28 cleavage site and its amino acid 
sequence motif recognized by this proteinase. 
Etrect of deletion mutation on prot.einase activity 
The first proteinase domain was predicted to be at 3.5 to 4.2 kb from 
the 5' end of the MHV-JHM gene 1 (Lee et al., 1991). To define more 
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precisely this putative proteinase domain, a deletion analysis was 
performed. Plasmid pT7-NBgl containing nucleotides 187 to 5273 of gene 1, 
was used as the parental construct and generated three in-frame deletion 
plasmids pT7-NAc, pT7-N27, and pT7-N29 (see Fig. 3). The plasmids were 
transcribed by T7 RNA polymerase and translated in rabbit reticulocyte 
lysates in the presence of 35S-Met, and the protein products were analyzed 
directly or after immunoprecipitation with anti-p28 serum by SDS-PAGE 
(Fig. 9A and B). The pT7-NBgl translation yielded proteins of 
approximately 188 kDa, 160 kDa, and 28 kDa (Fig 9A, lane 2). This result is 
consistent with previous results which showed that the 188 kDa protein is 
the primary translation product and the 160 kDa and 28 kDa proteins are 
the products of an autoproteolytic cleavage (Baker et al., 1989). p28, the N-
terminal cleavage product, is immunoprecipitated with anti-p28 antibody 
(Figure 9B, lane 2). The p28 cleavage efficiency for pT7-NBgl translation 
products was approximately 70%, as determined by quantitation of p28 and 
the precursor polyprotein using a Betagen scanner. Truncation of a 0.9 kb 
region at the 3' end of the PCP-1 domain in plasmid pT7-NAc had little 
effect on proteinase activity. It was demonstrated that p28 cleavage 
efficiency of the polypeptide encoded by pT7-NAc was still approximately 
70% (Fig. 9A and B, lane 3). Furthermore, deletion of an internal 0.74 kb 
region between p28 and the proteinase domain had only a minor effect on 
the ability of the proteinase to cleave p28 from the precursor polyprotein (60-
65% cleavage efficiency), as shown by translation of pT7-N27 RNA (Fig. 9A 
and B, lane 4). These results are consistent with the prediction that the 
proteinase domain is located in the region from 3.5 to 4.2 kb from the 5'-end 
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Fig. 9. Effect of deletion mutation on proteolytic processing of p28. 
Linearized plasmid DNA was transcribed and translated in rabbit 
reticulocyte lysates in the presence of T7 RNA polymerase and 358-Met as 
described in Material and Methods. Equal TCA-precipitable radioactive 
counts of translation products were analyzed by PAGE in 10% 
polyacrylamide gels directly (A) and following immunoprecipitated with 
p28-specific antiserum (B). Lanes: 1) no RNA, 2) pT7-NBgl RNA, 3) pT7-
NAc RNA, 4) pT7-N27 RNA, and 5) pT7-N29 RNA. Lane M contained 14C-
labeled marker polypeptides; molecular weights are given in kilodaltons. 
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and that some spacing sequences between the proteinase and p28 can be 
deleted without abolishing p28 cleavage. However, a larger internal 
deletion of 1.6 kb (pT7-N29 RNA) resulted in an inability to cleave the p28 
protein, and the appearance of two protein products of approximately 95 
kDa and 90 kDa precipitable by p28 antiserum (Fig. 9B, lane 5). The 95 kDa 
band was likely to be the primary translation product from the pT7-N29, 
and the 90 kDa protein probably resulted from premature termination of 
translation, or from a inefficiently proteolytic cleavage at an alternative 
site. This result indicates that the internal region between the proteinase 
domain and the p28 cleavage site may act as a spacing region to provide a 
correct conformation essential for autoproteolytic activity. Alternatively, 
the protein product encoded by this region may play a supporting role in the 
processing of the polyprotein. Overall, these deletion studies supported the 
prediction of a proteinase domain at the 5' end S.5 to 4.2 kb region of gene 1 
and also suggested an important role for the spacing region between the 
proteinase domain and the cleavage site (Baker et al., 1998). 
Effect of proteinase inhibitors on the autoproteo]ytic activity of MHV PCP-1 
There are four classes of proteinases which have been proposed from 
the studies of cellular proteinases (Barrett and Salvesen, 1986). These four 
proteinases are serine proteinases, cysteine proteinases, aspartic 
proteinases and metallo-proteinases. Representatives of each of these 
proteinase classes have been found in viral systems, except for the 
metalloproteinases (Krausslich and Wimmer, 1988; Dougherty and Semler, 
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1993). Computer-assisted sequence analysis suggests that the first 
proteinase of murine coronavirus gene 1 is probably a papain-like cysteine 
proteinase with the conserved Cys-1137 and His-1288 as the catalytic 
residues (Gorbalenya et al., 1991). In order to determine ifMHV PCP-1 was 
indeed a cysteine proteinase, we tested the sensitivity of the proteolytic 
activity to a variety of proteinase inhibitors in rabbit reticulocyte lysate 
translation reactions of in vitro transcribed pT7-N27 RNA (see Fig. 10 and 
Table 3). The proteinase inhibitors tested included a general proteinase 
inhibitor ZnCl2, four cysteine proteinase inhibitors: cystatin, 
Iodoacetamide, and N-ethyl-maleimide and E-64, a cysteine and serine 
proteinase inhibitor leupeptin, a serine proteinase inhibitor APMSF [94-
(amidinophenyl)-methanesulfonylfluoride], an aspartic proteinase 
inhibitor pepstatin A, and a metallo-proteinase inhibitor EGTA 
{[ethylenebis(oxyethlenenitrilo)]-tetraacetic acid}. The effect of a wide range 
of concentrations of each inhibitor on p28 processing was tested to achieve 
the optimal concentration for each of these inhibitors. The optimal 
concentration had no effect on the overall efficiency of the translation 
reaction but did inhibit specific proteinase activity. The optimal amounts of 
these selective proteinase inhibitors were added to the in vitro translation 
reaction of pT7-N27 RNA before the incubation at sooc. The 35S-Met labeled 
translation products were analyzed by 10% SOS-PAGE gel and 
autoradiography. The radioactivity of the precursor polyprotein and the 
cleavage product p28 were quantitated by Betagen scanning to determine 
the p28 cleavage efficiency (or the proteolytic activity of MHV PCP-1). The 
cleavage efficiencies were normalized after setting the cleavage efficiency of 
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Fig. 10. Inhibition of the proteolytic activity of MHV PCP-1 by proteinase 
inhibitors. Approximately 200 ng of pT7-N27 RNA were translated in rabbit 
reticulocyte lysates in the presence of 35S-Met as described in the Materials 
and Methods. The optimal amount of the selective proteinase inhibitor was 
added to the in vitro translation reaction of pT7 -N27 RNA prior to 
incubation at 30°C for 90 min. The 35S-Met labeled protein product was 
analyzed by electrophoresis in a 10% acrylamide -- 0.1 % SOS gel and 
autoradiography. A. Lanes: 1) no inhibitors, 2) 0.1 mM ZnCl2, 3) 0.14 mM 
cystatin. B. Lanes: 1) no inhibitors, 2) 0.1 mM ZnC12, 3) 0.2 mM 
iodoacetamide, 4) 2.5 mM N-ethyl-maleimide, 5) 0.5 mM E64, 6) 0.8 mM 
leupeptin, 7) 1.00 mM APMSF, 8) 1.0 mg/ml pepstatin A and 9) 8.0 mM 
EGTA. 
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Table 3. Effect ofproteinase inhibitors on the autoproteolytic activity of the MHV PCP-1 proteinase. 
Iphibitor Proteinase Family Concentration Cleavage Efficiency Inhibition(%) 
No inln'bitor 
------ ------
100% 
ZnCl2 general O.lOmM 82% 18% 
cystatin cysteine 0.14mM 82% 18% 
iodoacetamide cysteine 0.20mM 82% 18% 
N-ethyl-maleimide cysteine 2.50mM 77% 23% 
E-64 cysteine 0.50mM 82% 18% 
leupeptin serine/cysteine 0.80mM 91% 9% 
APMSF serine 1.00mM 100% 
pepstatinA ~partic 1.0 ug/ml 100% 
EGTA metallo- 8.00mM 100% 
Ut 
00 
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in vitro translation reaction without proteinase inhibitors as 100%. The 
proteinase inhibitory effect was estimated roughly by comparing 
radioactivity in p28 and precursor polyproteins and finally determined by 
calculating the decrease of the cleavage efficiency in the presence of 
proteinase inhibitors. 
ZnCl2 was shown to inhibit proteolytic activity in previous studies 
and used as the positive control (Denison and Perlman, 1986; Denison et al., 
1992; Baker et al., 1989). In the presence of ZnCI2 (Fig. 10 and B, lanes 2), 
the intensity of p28 was decreased (as well as the intensity of the large 
cleaved product plOO) as compared to the cleavage products of in vitro 
translation without proteinase inhibitors (Fig. lOA and B, lanes 1). 
Correspondingly, the intensity of the precursor polyprotein was increased 
as compared to that from the negative control without the proteinase 
inhibitor (Fig lOA and B, lanes 1 and 2), confirm that ZnCl2 inhibits the 
proteolytic activity ofMHV PCP-1. 
In the presence of four cysteine specific proteinase inhibitors: 
cystatin, Iodoacetamide, N-ethyl-maleimide and E64, the relative ratios of 
p28 to the precursor polyprotein were also decreased (Fig. lOA, lane 3; Fig. 
lOB, lanes 3 to 5 ). And these specific cysteine proteinase inhibitors were 
shown to inhibit proteolytic activity approximately to the same level as 
ZnCl2. An inhibitor to both cysteine and serine proteinases, leupeptin, had 
some inhibitory effect on the proteolytic activity (Fig. lOB, lane 6), consistent 
with the published data (Denison et al., 1992). In contrast, the 
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representatives of the serine proteinase inhibitor--APMSF, the aspartic 
proteinase inhibitor--pepstatin A, and the metallo-proteinase inhibitor--
EGTA, showed little or no inhibition of the proteolytic activity (Fig. lOB, 
lanes 7, 8, 9 respectively). The inhibition of the proteolytic activity of MHV 
PCP-1 by inhibitors of cysteine proteinases but not by inhibitors of serine 
proteinases, aspartic proteinases, and metalloproteinases supports the 
hypothesis that MHV PCP-1 is probably a papain-like cysteine proteinase. 
Effect of site-specific mutations of the putative MHV PCP-1 catalytic 
residues Cys-1137 and His-1288 on proteolytic processing mp28 
Amino acid sequence homology searches and the proteinase 
inhibition studies described above suggested that MHV PCP-1 is a papain-
like cysteine proteinase with characteristic catalytic residues of Cys and 
His. Among the Cys and His residues within the predicted proteinase 
domain, Cys-1137 and His-1288 are the only two residues conserved among 
all the cellular and viral papain-like cysteine proteinases and thus were 
predicted to be the catalytic amino acids (Gorbalenya et al., 1991). To 
determine if the predicted residues were indeed essential for catalytic 
activity, these putative catalytic amino acids were altered by site-directed 
mutagenesis (see Fig. 11). His-1317 and Cys-1172 in the proximity were also 
altered by site-directed mutagenesis for comparison. 
Site specific mutagenesis was performed by the method of 
Hutchinson and co-workers (1978) using single-strand pS-N27 DNA and 
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Fig. 11. The amino acid sequence of the proposed first papain-like cysteine 
proteinase domain (PCP-1) of MHV-JHM gene 1. Cys-1137 and His-1288 
marked by black triangles were predicted to be the catalytic residues of 
MHV PCP-1 (Gorbalenya et al., 1989). The putative catalytic residues and 
two control residues (marked by white triangles) were subjected to site-
specific mutagenesis analysis. 
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oligonucleotides containing degenerate sequences at the specific 
nucleotides selected for mutation (see Table 2). The procedures were 
described in the Promega protocol of the Altered Sites in vitro mutagenesis 
system (Fig. 7, in Materials and Methods), which uses a phagemid vector 
pSELECT-1 (Lewis and Thompson, 1990). The gene 1 fragment from 
plasmid pT7-N27 (3.5 kb Pvu 11-EcoR I fragment) was inserted into the 
polylinker region of pSELECT-1 (between the Sma I and BamH I sites), and 
the recombinant plasmid was designated pS-N27. Single-strand pS-N27 
DNA was prepared by standard methods and serves as the template for 
mutagenesis reactions. Plasmid DNA replication was primed by two 
synthetic oligonucleotides: one restores ampicillin resistance to the 
plasmid and allows the selection of the mutant plasmids, and the other was 
designed to encode mutations at specific codons of the MHV gene 1 
polyprotein. The two primers were added in excess so that they will be 
simultaneously incorporated into the same DNA strand during replication 
and produce double mutants selectable by ampicillin. Individual mutants 
at each site were identified by DNA sequencing and listed in Table 1. 
Plasmid DNAs encoding amino acid substitutions of each position were 
linearized by digestion with EcoR I, transcribed and translated in vitro. 
The 35S-Met labeled protein products with equivalent TCA-precipitable 
radioactivity are immunoprecipitated by p28 specific antiserum and 
analyzed by electrophoresis in a 10% polyacrylamide gel. 
The putative catalytic residue, Cys-1137 was substituted to Tyr, Arg, 
Ser, Gly, or Trp. The polypeptides containing these mutations all resulted 
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in a total loss of p28 and corresponding increase of an uncleaved precursor 
polypeptide (Fig. 12A). In contrast, mutations of Cys-1172 to Asn or Ser 
revealed no alteration in the cleavage of p28 (Fig. 12B). The loss of the 
proteinase activity by mutating Cys-1137 to a variety of amino acids of 
different properties confirmed the importance of this specific residue. 
Thus, Cys-1137 is indeed essential for the proteinase function. 
Mutation of the putative catalytic residue His-1288 to Thr or Arg also 
inactivated proteinase activity (Fig. 13A). Therefore, His-1288 as well as 
Cys-1137 is an essential residue for the proteinase activity. Interestingly, 
substitutions of His-1317 to Gin and Ser (Fig. 13B), also resulted in a 10-20% 
reduction in the production of ·p28, as determined by quantitation of 
cleavage products using a Betagen scanner. Substitution of His-1317 to Val 
or Pro (Fig. 13B) resulted in significant reductions in proteolytic processing 
to release p28. In particular, the substitution of Pro at position 1317 
completely eliminated the production of p28 and resulted in a primary 
translation product which migrated slightly faster on the gel (Fig 13B). 
This is not surprising since the addition of a Pro residue may cause 
significant alteration in the protein folding. These data are consistent with 
the idea that His-1317, considered as a non-catalytic residue of the 
proteinase, may play a role in maintaining conformation of the proteinase 
domain to allow accurate and efficient cleavage of p28. 
The above site-mutagenesis analysis of Cys-1137, His-1288, Cys-1172 
and His-1317 demonstrated that the catalytic residues of this proteiriase are 
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Fig. 12. Effect of site-specific mutation at the putative MHV PCP-1 catalytic 
residue Cys-1137 on proteolytic processing of p28. A series of mutants at 
Cys-1137 and control Cys residue at position 1172 were generated by 
oligonucleotide-directed single-strand DNA mutagenesis as described in 
the Materials and Methods. Wild type or mutant plasmid DNA pS-N27 was 
linearized by EcoR I digestion and used as the template in a coupled in vitro 
transcription/translation reaction which was performed as described in the 
Materials and Methods. Equal TCA counts of in vitro translation products 
were immunoprecipitated by p28-specific antiserum and analyzed by 10% 
SDS-PAGE. A. Lanes show products encoding the following amino acids at 
the position 1137: no RNA, wild type (Cys), Tyr, Arg, Ser, Gly, and Trp; B. 
Lanes show products encoding the following amino acids at position 1172: 
no RNA, wild type (Cys), Asn, and Ser. 
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Fig. 13. Effect of site-specific mutation at the putative MHV PVP-1 catalytic 
residue His-1288 on proteolytic processing of p28. Various His-1288 
mutants and control His-1317 mutants in pS-N27 were analyzed as in Fig. 
12. A. Lanes show products encoding the following amino acids at position 
1288: no RNA, wild type, Thr and Arg; B. Lanes show products encoding 
the following amino acids at position 1317: no RNA, wild type, Gln, Val, 
Ser, and Pro. 
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Cys-1137 and His-1288, and that it belongs to the family of papain-like 
cysteine proteinases (Baker at al., 1993). 
Determining the amino-terminal amino acid sequence of the protein 
.Uacent to p28 
Studies on viral proteinases have shown that these proteinases have 
a high degree of specificity for their specific cleavage sites (Dougherty and 
Semler, 1993). For example, in picornaviruses, proteinase 2A cleaves 
predominantly at the Tyr(Pl)-Gly(Pl') dipeptide bond and proteinase SC 
recognizes Gln/Glu(Pl)-Gly/Ser/Ala(Pl ') di peptide bond (Palmenberg, 
1990). The specificity for cleavage is not only shown in the amino acids 
forming the dipeptide bond to be cleaved or the scissile bond, but also in 
some surrounding residues which may be important to maintain the 
appropriate conformation for cleavage site presentation (K.rausslich and 
Wimmer, 1988; Palmenberg, 1990; Dougherty and Semler, 1993). According 
to molecular weight analysis, the p28 cleavage site is expected to be at 
approximately 1 kb from 5' end of MHV gene 1. This region contains 
several conventional cleavage sites (Tyr-Gly, Gly-Cys, Gly-Leu, etc.) similar 
to the cleavage sites of poliovirus proteinases 2A, and Sindbis virus 
proteinase nsP2. Previously, Soe et al. (1987) predicted Tyr-257--Gly-258 and 
Tyr-272-Gly-273 as the potential candidates for the p28 cleavage site. 
To identify the actual cleavage site, a direct approach was used to 
isolate the cleavage product downstream of p28 and sequence its N 
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terminus. The most critical point for conventional protein sequencing is to 
prepare a sufficient quantity of protein sample {10-1,000 picomole, 0.5-50 µg 
of a 50 kDa molecule). Since E. coli and yeast expression systems have been 
developed, they are frequently used to overexpress eukaryotic proteins for 
purification purposes. Previous studies have shown that viral proteinases 
can be highly expressed in these systems and still retain their proteolytic 
activities (Ivanoff et al. , 1986; Nicklin et al. , 1988; Alvey et al. , 1991). We 
have tried an E.coli protein overexpression system (PET system, Novagen) 
for expressing the gene 1 protein encoded in pT7-N27. However, it seems 
that MHV PCP-1 is highly toxic to bacteria and we were unable to express 
sufficient amounts of the protein product using this system. 
To get around the limit of the requirement for microgram quantities 
of the pure protein, we chose to isolate a radiolabeled in vitro cleaved protein 
adjacent to p28 and subject the protein to amino-terminal microsequencing 
(see Fig. 14). The protein was generated by in vitro transcription and 
translation of our smallest in-frame deletion construct pT7-N27 which still 
maintains active proteolytic processing of p28 (Baker et al., 1993). As shown 
in previous deletion analysis of the PCP-1 domain, in vitro translation of 
pT7-N27 generates a precursor polyprotein of 128 kDa which is 
autoproteolytically cleaved by MHV PCP-1 to yield p28anda100 kDa protein 
(plOO) (Baker et al., 1993). We found that pT7-N27 serves as an excellent 
template for an efficient transcription and subsequent translation reaction 
which can produces a large quantities of protein products. In addition, the 
128 kDa precursor and 100 kDa C-terminal cleavage product were easily 
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Fig. 14. Strategy of N-terminal protein sequencing to identify the p28 
cleavage site. The radiolabeled C-terminal cleaved 100 kDa peptide (plOO) 
downstream of p28 was generated by in vitro transcription/translation 
reaction of pT7-N27 and targeted for N-terminal microsequencing to 
determine the p28 cleavage site. 
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resolved on a 7.5% SDS-polyacrylamide gel which allowed us to isolate the 
target 100 kDa protein. Thus, in vitro translation products of pT7-N27, 
labeled with either SH-Leu, SH-Val or S5S-Met were synthesized, separated 
by electrophoresis in a polyacrylamide gel, and transferred to PVDF 
membrane (Fig. 15). The 100 kDa protein was identified by autoradiography 
and subjected to microsequencing as described in Materials and Methods. 
The sequencing profile generated from samples labeled with SH-Leu 
indicated that Leu occupied amino acid positions 5, 18 and 22 from the 
cleavage site (Figure 16). Microsequencing of the 100 kilodalton protein 
labeled with SH-Val revealed Val at positions 1 and 7 (Fig. 16). 
Microsequencing of the 100 kDa protein labeled with S5S-Met indicated that 
there was no Met at the first 25 positions from the cleavage site (data not 
shown). By aligning this profile with the amino acid sequence deduced 
from the MHV-JHM nucleotide sequence (Soe et al., 1987; Lee et al., 1991), 
we identified the cleavage site for the generation of p28 as the Gly-247 (Pl)-
Val-248 (Pl') dipeptide bond (see Fig. 17). 
Effect of sit.e-specific mutations surrounding the cleavage sit.e on proteolytic 
processing of p28 
To determine the amino acid sequence requirements for the PCP-1 
recognition of the p28 cleavage site, we have targeted 8 amino acid residues 
including P5 to P3' surrounding p28 cleavage site for site-directed 
mutagenesis (see Fig. 18). A variety of site-specific mutants (total 42) at 
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Fig. US. Schematic diagram of the autoradiogram of radiolabeled protein 
electrotransferred to the PVDF membrane. 100 µl of pT7-N27 in vitro 
translation products were separated in a 7.5% SDS-PAGE gel and 
transferred to lmmobilon polyvinylidene difluoride (PVDF) membrane 
(Millipore) as described in the Materials and Methods. The 
electrotransferred membrane was exposed to a X-ray film and 
autoradiogramed. The autoradiogram was matched with the PVDF 
membrane to identify plOO labeled with 35S-Met in the membrane. 3ff-Leu 
or 3ff-Val labeled plOO were not visible in the autoradiogram and were 
localized in parallel to 35S-Met labeled plOO. All radiolabeled plOO was cut 
out and subjected to automated N-terminal protein sequence analysis to 
determine the p28 cleavage site. 
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Fig. 18. N-terminal sequence analysis of radiolabeled plOO. plOO was 
derived from the in vitro transcription/translation reaction of plasmid pT7-
N27 and were labeled with either 35S-Met, 3H-Leu, or 3H-Val. The 
radiolabeled samples on the PVDF membrane were identified by 
autoradiography and subjected to microsequencing analysis based on the 
Edman-degradation reaction. Radioactivity released at each cycle was 
quantitated using a Beckman scintillation counter and counts per minute 
(cpm) were plotted. The amino acid sequence in single letter codes shown 
at the top of the graph corresponds to amino acid 248 to 272 of the deduced 
amino acid sequence of MHV-JHM gene 1. 
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Fig. 17. Schematic diagram of the putative p28 cleavage site. Partial amino 
acid sequence of the potential cleavage site region is shown, in which the 
cleavage site Gly-247-Val-248 predicted from protein microsequencing 
analysis is indicated by a black triangle and the previously proposed 
cleavage site (Soe et al., 1987) is marked by an asterisk(•). The amino acids 
underlined were targeted for site-specific mutagenesis analysis to further 
characterize the sequence motif recognized by MHV PCP-1 
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Fig. 18. Nomenclature of the amino acid residues surrounding a cleavage 
site for a proteinase. The figure is modified from Dougherty and Semler, 
1993, and the nomenclature was according to Schechter and Berger, 1967. 
The peptide bond to be cleaved is indicated by an arrow, and amino acids 
upstream of the scissile bond are designed as Pl, P2, P3, P4, P5, etc. and 
amino acids downstream as Pl', P2', P3', P4', P5' , etc. A schematic 
proteinase domain is drawn at the bottom with the subsites (S5 through S5') 
of the substrate binding pocket indicated. The complexity of the substrate-
binding pocket of an individual proteinase determines the requirement of 
its cleavage site, or its specificity. 
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Positions from P5 to P3' (see Fig.18) were created by single-strand DNA 
mutagensis and isolated by direct plasmid DNA sequencing as previously 
described (see Materials and Methods, Table 2). Individual mutant pS-N27 
DNAs at each position were linearized by digestion with EcoR I, transcribed 
and translated in vitro as described above. The 35S-Met labeled protein 
products with equal TCA-precipitable radioactivity were directly analyzed 
by 10% SDS-PAGE to determine the effect of amino acid substitutions on p28 
cleavage (Fig. 19 to 26). Samples of in vitro translated proteins with 
equivalent radioactivity were further analyzed by immunoprecipitation 
with p28 specific antiserum, and the autoradiogram showed the amount of 
p28 cleaved from the wild-type pS-N27 and mutant polypeptides at these 
positions (Fig. 27). 
As shown in Figure 19, mutation of Gly-24 7 at the Pl position to Ala, 
Asp, Asn or Val resulted in a dramatic decrease in the yield of p28 
generated by autoproteolytic processing of the mutant polyprotein. 
However, mutation at the Pl position did not completely abolish proteinase 
activity as is seen in a mutant of the catalytic site of PCP-1 in which the 
catalytic residue Cys-1137 was mutated to Ser (Figure 19, lane C) (Baker et 
al., 1993). When the products of the in vitro translation reaction were 
immunoprecipitated with the anti-serum to p28, we detected two p28 
specific bands (Figure 27, Pl position), indicating that a low level of 
aberrant processing may also be taking place in the Pl mutants. Such 
aberrant autoprocessing of a polypeptide encoding mutations in the 
cleavage site has also been reported for the poliovirus 2A proteinase {Hellen 
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Fig. 19. In vitro translation protein products of wild type pS-N27 and 
mutants of Gly-247 (Pl). Site-specific mutations were introduced by 
degenerate oligonucleotide-directed mutagenesis as described in the 
Materials and Methods. Linearized plasmids were translated in the T7 
RNA polymerase coupled rabbit reticulocyte lysates in the presence of 35S-
Met and translation products were analyzed by 10% SOS-PAGE. Specific 
mutations at the Pl position are indicated by amino acids A (Ala), D (Asp), 
N (Asn), and V (Val) at the top of the corresponding lanes. Additional 
lanes are: M, molecular weight marker; N, no RNA; Wt, wild type (Gly-
247) pS-N27 translation products; C, control polypeptide with inactive PCP-1 
in which the catalytic residue of the proteinase, Cys-1137, was mutated to 
Ser (Baker et al., 1993). 
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et al., 1992). This aberrant processing may be due to an alteration in the 
presentation of the cleavage site to the proteinase domain. Clearly, Gly-247 
at the Pl position is an important determinant of the cleavage efficiency and 
specificity of p28. 
Like Gly-24 7 at the Pl position, mutation of Arg-246 at the P2 position 
to His, Leu, Pro, Ser, or Tyr also resulted in dramatic reduction in cleavage 
of p28 (Fig. 20 and 27). No p28 from all these mutant polyproteins was 
detectable even after a long exposure of the SDS-PAGE gel. Thus, Arg-246 
at the P2 position is also critical for efficient cleavage of p28. These results 
indicate that the P2 residue (Arg-246) plays an important role for cleavage-
site determination, which is consistent with the studies of the cleavage sites 
for other viral cysteine proteinases in tobacco etch virus, and 
Hypovirulence-associated virus (Carrington and Herndon, 1992; Shapira 
and Nuss, 1991). 
In contrast, mutations at the surrounding positions including P3, 
P4, Pl', P2', and P3' had little or no effect on cleavage efficiency. 
Polyproteins encoding mutations at the Pl', P2', P3', P3 or P4 positions 
generally maintained equivalent cleavage of p28 as compared to the wild 
type polyprotein (Fig. 21 to 25, and Fig. 27). At the P3 or P4 position, the wild 
type has been selectively mutated from Tyr-245 to Cys, Phe, Pro, Arg, or Ser, 
or from Gly-244 to Ala, Asp, Phe, His, Leu, Ser, Val, or Tyr, respectively. 
Most of these substitutions result in drastic changes in the side chains of 
the amino acids, but all the mutations had little or no effect on the cleavage 
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Fig. 20. In vitro translation protein products of wild type pS-N27 and 
mutants of Arg-246 (P2). Site-specific mutagenesis analysis was performed 
as described in Fig. 19. Specific mutations at the P2 position are indicated 
by amino acids Y(Tyr), S (Ser), P (Pro), L (Leu), and H (His) at the top of the 
corresponding lanes and lane Wt represents wild type Arg-246 pS-N27 
translation products. 
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Fig. 21. In vitro translation protein products of wild type pS-N27 and 
mutants of Tyr-245 (P3). Site-specific mutagenesis analysis was performed 
as described in Fig. 19. Specific mutations at the P3 position are indicated 
by amino acids C (Cys), F (Phe), P (Pro), R (Arg), and S (Ser) at the top of the 
corresponding lanes and lane Wt represents wild type Tyr-245 pS-N27 
translation products. 
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Fig. 22. In vitro translation protein products of wild type pS-N27 and 
mutants of Gly-244 (P4). Site-specific mutagenesis analysis was performed 
as described in Fig. 19. Specific mutations at the P4 position are indicated 
by amino acids A (Ala), D (Asp), F (Phe), H (His), L (Leu), S (Ser), V (Val), 
and Y (Tyr) at the top of the corresponding lanes and lane Wt represents 
wild type Gly-244 pS-N27 translation products. 
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Fig. 23. In vitro translation protein products of wild type pS-N27 and 
mutants of Val-248 (Pl'). Site-specific mutagenesis analysis was performed 
as described in Fig. 19. Specific mutations at the Pl' position are indicated 
by amino acids A (Ala), D (Asp), G (Gly), S (Ser), T (Thr), L (Leu), F (Phe), R 
(Arg), and H (His) at the top of the corresponding lanes and lane Wt 
represents wild type Val-248 pS-N27 translation products. 
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Fig. 24. In vitro translation protein products of wild type pS-N27 and 
mutants of Lys-249 (P2'). Site-specific mutagenesis analysis was performed 
as described in Fig. 19. Specific mutations at the P2' position are indicated 
by amino acids A (Ala), M (Met), R (Arg) and T (Thr) at the top of the 
corresponding lanes and lane Wt represents wild type Lys-249 pS-N27 
translation products. 
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Fig. 25. In vitro translation protein products of wild type pS-N27 and 
mutants of Pro-250 (P3'). Site-specific mutagenesis analysis was performed 
as described in Fig. 19. Specific mutations at the P3' position are indicated 
by amino acids H (His), L (Leu), and R (Arg) at the top of the corresponding 
lanes and lane Wt represents wild type Pro-250 pS-N27 translation 
products. 
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of p28 (Fig. 21 and 22). At the Pl' position, which was shown to be 
important for some viral cleavage sites, Val-248 (with small branched side 
chain) was replaced by amino acids with similar small side chains (Ala, 
Gly, Ser or Thr), amino acids with a large side chain or an aromatic chain 
(Leu, or Phe), or charged amino acids (Asp, Arg, or His). All nine mutant 
polypeptides had about the same or even slightly higher p28 cleavage as 
compared to the wild-type polyprotein (Fig. 23 and 27). Thus, this result 
enabled us to rule out the importance of the Pl' position for the cleavage site 
determination. At two other positions (P2' and P3') downstream of the 
peptide bond to be cleaved, substitutions of Lys-249 (P2') with Ala, Met, Arg, 
or Thr, and Pro-250 (P3') with His, Leu, or Arg had no effect on p28 cleavage 
(Fig. 24, 25 and 27). Thus, these five positions are less important for 
cleavage site determination. 
Interestingly, mutation of the P5 position, Arg-243, did have an 
impact on the cleavage of p28. Mutation of Arg to Ala, Ile, or Thr resulted 
in a significant reduction in p28 (Fig. 26 and 27). Substitution of Arg with 
Lys, another similar positively charged amino acid, also reduced the 
cleavage of p28 (Fig. 26 and 27). This result is somewhat surprising 
because Lys is the wild-type amino acid at this position in the A59 strain of 
MHV. This observation raises a question as to the role of a different amino 
acid at the P5 position for MHV JHM versus A59 (see Discussion). The 
results of all the mutation analysis at the P5 position indicate that Arg-243 
may play an important role, presumably a structural role, maintaining an 
appropriate conformation of the cleavage site. 
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Fig. 26. In vitro translation protein products of wild type pS-N27 and 
mutants of Arg-243 (P5). Site-specific mutagenesis analysis was performed 
as described in Fig. 19. Specific mutations at the P5 position are indicated 
by amino acids A (Ala), I (Ile), K (Lys) and T (Thr) at the top of the 
corresponding lanes and lane Wt represents wild type Arg-243 pS-N27 
translation products. 
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Fig. 27. Immunoprecipitation analysis of p28 from in vitro translation 
products of wild type pS-N27 and mutants at positions from P5 to P3' of the 
cleavage site. Site-specific mutagenesis on the positions from P5 to PS' was 
performed as described in Materials and Methods. Translation products 
were generated by in vitro transcription/translation of various pS-N27 
plasmid DNAs and equal TCA-precipitable counts from each reaction were 
immunoprecipitated using anti-sera specific to p28. Immunoprecipitation 
products were analyzed by 10% SOS-PAGE. The region corresponding to 
p28 is shown for each mutant. The amino acid at the site examined is 
shown above each lane. 
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Previous studies on proteolytic processing of p28 suggested that the 
cleavage site for p28 generation is the Tyr-257 and Gly-258 dipeptide bond 
(Soe et al.. , 1987). This suggestion was based primarily on a search of the 
N-terminal region of the polymerase polyprotein for homology to a limited 
number of known viral proteinase cleavage sites. Certain Tyr-Gly (Y-G) 
sites (among others) are recognized by enterovirus 2A proteinases 
(Palmenberg, 1990). Mutation of Tyr-257 to either Ala or Asp and of Gly-258 
to Ala, Asp, Phe or Leu had no effect on p28 cleavage nor any effect on the 
mobility of the p28 protein (Fig. 28). These results indicated that Tyr-257 
and Gly-258 are not essential for proteolytic processing of p28. In addition, 
the substitutions of residues at positions 257 and 258 do not appear to have 
any effect on the presentation of the nearby authentic cleavage site Gly-247-
Val-248. 
Overall, the results from our site-specific mutagenesis analysis at 
eight amino acids surrounding p28 cleavage site Gly-247-Val-248, indicate 
that Gly-247 at the Pl position and Arg-248 at the P2 position are the major 
determinants for efficient cleavage of p28 by MHV PCP-1. In addition, 
among the surrounding residues, Arg-243 at the P5 position may be 
important, perhaps in maintaining a special conformation for the cleavage 
site. 
In summary, the studies of this dissertation showed that the first 
papain-like cysteine proteinase (PCP-1) domain responsible for 
autocleaving the N-terminal peptide p28 from the MHV-JHM polymerase 
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Fig. 28. Effect of site-specific mutation at the previously predicted p28 
cleavage site Tyr-257 and Gly-258 on proteolytic processing of pS-N27 
translation products. Site-specific mutagenesis was performed as 
described in the Materials and Methods. Specific mutations at Gly-258 and 
Tyr-257 are indicated by amino acids Ala, Asp, Phe, Leu, Lys, and Arg at 
the top of the corresponding lanes. Additional lanes are: M, 14C-labeled 
molecular weight polypeptide marker, masses are given in kilodaltons; N, 
no RNA; Wt, wild type pS-N27 translation products. 
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Gly258 Tyr257 
M N Wt Ala Asp Phe Leu Cys Arg 
200 -
97 -
68 -
43 -
29 - ~ p28 
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polyprotein is located at the 5' end 3.5-4.2 kb of gene 1. MHV PCP-1 is 
indeed a member of the family of papain-like cysteine proteinases which 
utilizes Cys-1137 and His-1288 as the catalytic residues. Additionally, MHV 
PCP-1 cleaves at Gly-247 and Val-248 dipeptide bond to release p28. For this 
p28 cleavage site, Gly-24 7 (Pl) and Arg-246 (P2) are major determinants, 
and an important conformation is required for this cleavage site which 
might be determined by some surrounding residues including Arg-243 at 
the P5 position. 
CHAPl'ER IV 
DISCUSSION 
Proteolytic processing of a polyprotein precursor is a common and 
essential event in the replication of positive-strand RNA viruses including 
retroviruses. Viral polyprotein precursors are processed into functional 
subunits by viral and/or host cell proteinases (Krausslich and Wimmer, 
1988; Dougherty and Semler, 1993). During replication of MHV, three viral-
encoded proteinase domains, PCP-1, PCP-2, and 3C-Pro, are proposed to be 
responsible for separating the polymerase polyprotein (more than 750 kDa) 
into functional protein products. To date, the activity of only the first 
papain-like cysteine proteinase domain, PCP-1, has been demonstrated 
(Baker et al., 1989). PCP-1 acts to autocleave the amino-terminal portion of 
the MHV polymerase polyprotein, releasing p28 (Baker et al., 1989; 1993). 
The goal of this dissertation was to understand this particular processing 
event by characterizing the proteinase functional domain and the cleavage 
site specificity of the proteinase. 
This study demonstrated that the MHV-JHM PCP-1 proteinase 
domain, which is responsible for the proteolysis of p28 protein from the N-
terminus of the MHV gene 1 polyprotein, is located at 3.5-4.2 kb from the 5' 
end of gene 1 (see Fig. 3 and Fig. 9). It was shown that some of the 
intervening sequence between the proteinase domain and the cleavage site 
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can be deleted without a significant effect on the proteolytic cleavage (Baker 
et a/,., 1993). Also, the kinetics of p28 processing during in vitro translation 
of the MHV genomic RNA (data not shown) suggest that p28 is cleaved as 
soon as the proteinase domain is synthesized. Since the proteinase has 
been shown to work in cis to release p28, p28 processing is probably a co-
translational event (Baker et al., 1989). In addition, it is likely that the 
tertiary conformation of the polyprotein, particularly that formed by 
sequences neighboring the cleavage site or the proteinase domain, are 
critical for efficient proteolytic processing. This conclusion is supported by 
the failure of pT7-N29, which has an internal deletion of 1.6 kb, to generate 
p28. 
To determine if MHV PCP-1 is a cysteine proteinase, we tested a 
variety of proteinase inhibitors and monitored the effect of these inhibitors 
on the proteolytic processing of p28. The level of p28 processing was shown 
to be specifically reduced by cysteine proteinase inhibitors, but not by 
inhibitors of serine proteinases, aspartic proteinases, and metallo-
proteinases (see Fig. 9). Furthermore, mutagenesis studies have identified 
Cys-1137 and His-1288 as critical residues for the proteinase activity of 
MHV-JHM PCP-1 (Baker et al., 1993). These two residues have been 
proposed to be the catalytic residues of this proteinase on the basis of the 
sequence similarity with cellular and viral papain-like cysteine proteinases 
(Gorbalenya et al., 1991). The substitutions of amino acids of diverse 
properties for Cys-1137 and His-1288 resulted in the total loss of proteinase 
activity which confirmed that these amino acids are indeed at the catalytic 
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center. In contrast, substitutions of the neighboring His-1317 or Cys-1172 
residues did not inactivate proteinase activity, except for the Pro 
substitution at the His-1317 position, which is expected to alter global 
protein conformation. These studies thus strongly supported the computer 
prediction that MHV PCP-1 is a new member of the family of papain-like 
cysteine proteinases. 
Coronavirus PCP-1 adds to the growing list of the viral papain-like 
proteinases. Previous studies have suggested that Sindbis virus (SV), 
equine arteritis virus (EA V), rubella virus, hepatitis E virus, plant virus 
tobacco etch virus (TEV) and hypovirulence-associated virus (HA V) all 
contain proteinase domains with homology to the family of cysteine 
proteinases and have conserved Cys and His residues essential for catalytic 
activity (Gorbalenya et al., 1991; K.oonin et al., 1992; Dougherty and Semler, 
1993). Among these viral cysteine proteinases, MHV PCP-1 appears to be 
related to PCP in another coronavirus superfamily member, equine 
arteritis virus (EAV) (den Boon et al., 1991; Snijder et al., 1992). EAV has a 
similar replication strategy and genomic organization to that of 
coronavirus MHV, but has only a 13-kb RNA genome. The product of the 
EAV papain-like cysteine proteinase is a 30 kDa protein, which is also 
derived from the N terminus of the ORFla protein of the polymerase gene, 
but the cleavage site is located at the C-terminal end of the proteinase. Like 
MHV PCP-1, this proteinase also acts only in cis (Snijder et al., 1992). For 
both MHV and EA V, the function of the released amino terminal peptide 
(p28 or p30) is not yet clear. 
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The second question addressed in this research was the site 
recognized by MHV PCPl for the cleavage release of p28. By N-terminal 
protein sequence analysis of the in vitro cleaved protein downstream of p28, 
the cleavage site for p28 was identified as the Gly-247 (Pl) and Val-248 (Pl') 
dipeptide bond (Fig. 16 and 1 7). Site-specific mutagenesis of eight residues 
surrounding the cleavage site from the P5 to PS' positions was performed to 
further characterize the sequence motif of the p28 cleavage site. A total of 
42 mutants were generated, with 3 to 9 mutants at each position. Mutations 
at Pl Gly-24 7 and P2 Arg-246 dramatically decreased the amount of p28 
cleaved from the mutant polyproteins compared to that from the wild type 
polyprotein. In contrast, the majority of the mutations at the five other 
positions (P3, P4, Pl', P2' and PS') had little or no effect on p28 processing 
and only a few mutants led to significant p28 cleavage. Surprising results 
were seen from the mutational analysis at the P5 position (Arg-243). 
Mutation of Arg-243 to Lys, another positive charged amino acid also 
reduced p28 cleavage as did three other mutations (Ala, Ile and Thr). The 
P5 residue is the only residue that varies within positions from P5 to P3' 
between two p28 cleavage sites of MHV ..JHM and -A59 strains (Soe et al., 
1987; Pachuk et al., 1989). The observation that strain JHM prefers Arg at 
the P5 position instead of Lys as in strain A59, is interesting, as it might 
result from a minor difference between PCP-1 domains of A59 and JHM. 
The extensive mutagenesis analysis of the cleavage site has shown 
that Gly-24 7 at the Pl position and Arg-246 at the P2 position are major 
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determinants of the p28 cleavage site recognized by MHV PCP-1. Since the 
Arg-243-Gly-244 dipeptide, appears only three residues upstream of the 
cleavage site (Arg-246--Gly-247), but is not recognized by MHV PCP-1, the 
conformation of the p28 cleavage site Gly-247-Val-248 (unknown at this 
point) or other surrounding amino acids must also be important for 
defining the cleavage site. Surrounding residues such as Arg-243 (P5), 
may be involved in maintaining the correct conformation of the cleavage 
site or for interacting with the substrate-binding pocket of the MHV PCP-1 
proteinase domain. 
The Gly-Val dipeptide bond at the p28 cleavage site appears to be 
similar to cleavage sites used by other viral papain-like cysteine proteinases 
(see Fig. 29). The cleavage site for the amino terminal product of the equine 
arteritis virus (EA V) polymerase polyprotein has been defined (Snijder et 
al., 1992). The EAV papain-like cysteine proteinase (PCP) cleaves at a Gly-
Gly dipeptide bond to release an amino terminal protein of 30 kDa. Snijder 
and co-workers have demonstrated by site-directed mutagenesis that the 
Gly residue at the Pl position was important for efficient autoproteolytic 
processing whereas the Gly residue at the Pl' position was more flexible to 
substitution (Snijder et al., 1992). In EAV, when the Pl Gly was replaced 
with Ala, there was a reduction in the amount of p30 detected; when the Pl 
Gly was replaced with Val, little or no processing of p30 was detected. 
However, the Gly at the Pl' position was tolerant of mutation to Ala or Val 
and proteolytic processing of p30 was detected. 
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Fig. 29. Comparison of known cleavage sites for viral papain-like cysteine 
proteinases. Viral proteinases are indicated, and protein junctions cleaved 
by Sindbis virus nsP2 proteinase are denoted. Amino acid sequences are 
shown in single letter codes and the arrow indicates the dipeptide bond 
being cleaved. MHV stands for mouse hepatitis virus, EA V for equine 
arteritis virus, TEV for tobacco etch virus, HA V for hypovirulence-
associated virus, and SV for Sindbis virus. 
Cleavage 
Viral Proteinase PS - P4 - P3 - P2 - Pl i Pl' - P2' - P3' - P4' 
MHV-JHM PCPl R G y R G v K p I 
EAV nsPl A G N y G G y N p 
TEV HC-Pro T y N v G G M N R 
HAV p29 L A R I G G R L N 
p48 D I L v G A E E G 
sv nsP2 (nsP1-nsP2) A D I G A A L v E 
(nsP2-nsP3) D G v G A A p s y 
(nsP3-nsP4) T G v G G y I F s 
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The best characterized cleavage sites for all identified viral cysteine 
proteinases are in two plant viruses: the tobacco etch virus helper 
component protease (TEV HC-Pro) and the proteinase p48 of hypovirulence-
associated virus (HA V) of the chestnut blight fungus. The cleavage site of 
TEV HC-Pro is also at a Gly-Gly dipeptide bond and both residues (Pl and 
Pl') are critical for efficient cleavage (Carrington et al., 1989; Carrington 
and Herndon, 1992). There are two PCP proteinases (p29 and p48) reported 
in HAV. HAV p29 and p48 utilize Gly-Gly and Gly-Ala as their cleavage 
sites respectively. The Pl Gly residue for both HAV cleavage sites is 
required for efficient cleavage (Choi et al., 1991a; 199lb; Shapira and Nuss, 
1991). Overall, a Gly at the Pl position is required by MHV, EAV, TEV and 
HAV cysteine proteinases for efficient cleavage activity; but the Pl' residue 
is somewhat flexible for MHV PCP-1, EAV PCP and HAV p48 recognition 
and processing. 
The amino acid residues surrounding these cleavage sites, the P2 
and P4 residues of the cleavage sites for both HC-Pro and p48 have been 
shown to be critical for the cleavage site determination. Similarly, the P2 
residue of p28 cleavage site for MHV-JHM PCP-1 is a critical residue, but 
the P4 residue does not seem to be as important for MHV PCP-1 cleavage as 
it is for HC-Pro and HA V p48 cleavages. The difference in the sequence 
motifs of these cleavage sites might result from the differences in the 
substrate-binding pockets of these viral cysteine proteinases. 
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Viral cysteine proteinases such as EAV PCP, TEV HC-Pro, and 
HA V p29 described above have been termed "leader" viral papain-like 
proteinases (Gorbalenya et al., 1991). These leader proteinases are located 
near their N termini of the respective polyproteins and mediate a single 
cleavage event in cis (or intramolecularly) at their own C termini. In these 
polyproteins, the cleavage sites are located 50-100 amino acids downstream 
of the catalytic cysteine residues (Snijder et al., 1992; Carrington et al., 1989; 
Choi et al., 199la; 1991b). In contrast to the leader proteinase, the MHV p28 
cleavage site (Gly-247-Val-248) is upstream of MHV PCP-1 and is separated 
from the catalytic residue Cys-1137 of PCP-1 by almost 900 amino acids 
(approximately 3 kb). We believe that MHV PCP-1 may be more similar to 
Sindbis virus nsP2 (classified as a "main" proteinase by Gorbalenya et al., 
1991) which cleaves the polyprotein precursor at multiple sites both in cis 
and in trans (Hardy and Strauss, 1989; de Groot et al., 1990, Shirako and 
Strauss, 1990). Although MHV PCP-1 is so far only known to release p28 
from the N-terminus of the polymerase polyprotein, it is possible that the 
mature polymerase polyprotein may possess several sites which may be 
cleaved in trans or in cis by MHV PCP-1. Questions remain about what the 
mature form of the PCP-1 protein is and whether there are additional 
cleavage sites in the polyprotein. 
Compared to cellular proteinases, viral proteinases have been 
shown to recognize specific amino acid sequence motifs (Dougherty and 
Semler, 1993). The characterization of the cis-cleavage site of p28 for MHV 
PCP-1 should help us predict additional cleavage sites in the polYJ>rotein. 
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Indeed, there are 16 other Arg-Gly (RG) sites in MHV-JHM polymerase 
polyprotein which may serve as potential targets for trans-cleavage by the 
mature PCP-1 product. We plan to subject these RG sites (the major 
determinants of the putative cleavage site recognized by MHV PCP-1) to 
future investigation in order to determine which ones are in fact recognized 
by the MHV PCP-1. These studies will help us to identify potential new 
processed products of MHV polymerase polyprotein. 
MHV PCP-1 is the first of three predicted proteinases in MHV 
demonstrated to be active. Interestingly, there is a second predicted 
papain-like cysteine proteinase domain approximately 2 kb downstream 
from the proteinase domain described here. MHV PCP-2 domain has a 
higher sequence homology to the only PCP domain suggested in the chicken 
coronavirus IBV ORFla polyprotein than does PCP-1. The biological 
activity of MHV PCP-2 domain has not yet been demonstrated. Because of 
the finding that the first papain-like proteinase works only in cis and 
requires at least some spacing regions between the cleavage site and the 
proteinase domain, it seems unlikely that the downstream papain-like 
proteinase domain will also cleave p28. Rather, it is more likely that the 
second proteinase has other cleavage sites. Significantly, the IBV gene 1 
polyprotein has only one PCP domain, a 3C-Pro domain (Gorbalenya et al., 
1989), and the N-terminal portion of ORFla polyprotein is substantially 
diverged from that of MHV. IBV also lacks regions corresponding to p28 
and the PCP-1 domain. Therefore, MHV PCP-2 may cleave in a region of 
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the coronavirus ORFla polyprotein which is more conserved between mv 
and MHV. 
The two papain-like cysteine proteinase domains are generally 
believed to mainly process the polyprotein portion encoded from the MHV 
ORFla, so the SC-Pro proteinase domain is probably responsible for the 
processing of the polyprotein portion from the ORFlb which is about 300 
kDa. Preliminary evidence suggests that MHV SC-Pro is active, and there 
are multiple potential cleavage sites which have been predicted in the 
ORFlb-encoded polyprotein by searching conventional poliovirus 3C 
cleavage sites (Q/E-G/S/A) (Lee et al., 1991). Further confirmation of the 
proteinase activity of MHV PCP-2 and SC-Pro domains are the prerequisite 
for future studies of the complicated proteolytic processing of MHV 
polymerase polyprotein. 
The long term goal of the studies of the proteolytic processing of 
MHV polymerase polyprotein is to define the complete proteolytic 
processing pathway of this polyprotein. Preliminary evidence has 
suggested that a plethora of cleavage events are likely to occur during or 
after translation of the coronavirus polymerase polyprotein (Denison et al., 
1991; 1992). Viral proteinases in Sindbis virus and poliovirus have been 
shown to play a pivotal role in the regulation of processing and enzymatic 
activity of viral nonstructural proteins including the polymerase protein 
(Shirako and Strauss, 1990; Strauss and Strauss, 1990; de Groot et al., 1990, 
Lemm and Rice, 1993; Shirako and Strauss, 1994; Dewalt and Semler, 1987). 
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Conceivably, MHV proteinases may play similar roles in the regulation of 
coronavirus replication. Future experiments can be directed to study the 
functional importance of p28 processing in coronavirus replication by 
introducing mutations at the p28 cleavage site by the unique high-frequency 
RNA recombination observed in MHV. Ultimately, the functions of p28 and 
other processed protein products of the polymerase polyprotein will be 
pursued. By studying the functions of all of these processed protein 
products from coronavirus polymerase polyprotein, it is possible to 
understand the molecular basis of the complex replication in coronavirus 
replication. Hopefully in the future, the studies of the molecular 
mechanism of coronavirus proteolytic processing will provide useful 
information for designing antiviral drugs to interrupt coronavirus 
replication and block coronavirus infection and pathogenesis. 
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